Courses & outcomes
Course descriptions and learning outcomes.
Interim Stream Review · Prototype
Stream Overview
What does learning in this stream look like across the program and within each year?
This workspace moves from a high-level orientation to an interactive curriculum portrait and then to searchable source records, helping reviewers understand the stream across the program, examine year-specific evidence, and verify the records behind the summary.
Evidence at a Glance
What curriculum evidence am I reviewing?
Teaching & topics
Sessions, topics, types, duration, and instructional characteristics.
Assessment
Assessment structure and available descriptions.
High-Level Overview of Learning
What does learning look like in this stream?
Overall focus
The BASE stream documents foundational professional roles, patient‑centred communication, basic patient assessment, the medication‑use process, evidence‑based practice, health informatics, regulatory/jurisprudence concepts, research methods and ethics across Years 1–3. Outcomes are organized across six courses and present knowledge, skills and attitudes tied to patient safety, population topics and culturally informed care.
Development across years
Documented emphasis shifts from Year 1 focus on professional identity, communication and evidence‑literacy toward Year 2 introduction of hospital processes, informatics, legislation and quality‑improvement concepts, and Year 3 concentration on systems‑level topics: advocacy, health promotion, culturally safe communication, program evaluation, leadership and implementation planning.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The BASE stream foregrounds behavioural, administrative, social and evidence-based pharmacy across Years 1–3. Documented outcomes emphasize pharmacist professional identity; patient‑centred communication (teach‑back, plain language, complex communication); medication‑use processes and dispensing documentation; monitoring, medication safety and error disclosure; evidence appraisal and drug‑information skills (systematic reviews, guideline use); basic informatics; jurisprudence and regulatory context; research methods and quality improvement; Indigenous health, social determinants and population‑level topics; and leadership and service design.
48Documented learning outcomes
246Documented topics
7AFPC roles represented
36CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
Outcomes show a mixed composition: recorded skills and knowledge are dominant with applied tasks and evidence‑use skills, while attitudes are present and focused on professional development, cultural awareness, and reflective practice.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 18
2024-2025n = 17
2023-2024n = 17
Year 2
2025-2026n = 17
2024-2025n = 16
2023-2024n = 15
Year 3
2025-2026n = 16
2024-2025n = 16
2023-2024n = 16
AFPC professional roles
Mappings emphasize Scholar, Professional and Leader‑Manager roles, indicating documented curriculum attention to evidence synthesis and scholarly reasoning, professional responsibilities and administrative/management responsibilities for pharmacists.
- Scholar
- Professional
- Leader-Manager
- Health Advocate
- Care Provider
- Other
Year 1
2025-2026n = 121
2024-2025n = 118
2023-2024n = 121
Year 2
2025-2026n = 138
2024-2025n = 119
2023-2024n = 120
Year 3
2025-2026n = 130
2024-2025n = 115
2023-2024n = 115
CCAPP curriculum topics
Top CCAPP topics represented are pharmacy law and regulatory issues, management and leadership, research methods, and patient/professional communications — reflecting documented emphasis on legal/regulatory knowledge, organizational skills, research literacy and communication in pharmacy practice.
- pharmacy law and regulatory issues
- management and leadership
- research methods
- patient and professional communications
- professional learning and development
- Other
Year 1
2025-2026n = 121
2024-2025n = 118
2023-2024n = 121
Year 2
2025-2026n = 138
2024-2025n = 119
2023-2024n = 120
Year 3
2025-2026n = 130
2024-2025n = 115
2023-2024n = 115
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 194 | 2024-2025 n = 176 | 2023-2024 n = 179 |
|---|---|---|---|
| pharmacy law and regulatory issues | 44% | 42% | 43% |
| management and leadership | 47% | 39% | 40% |
| research methods | 36% | 33% | 33% |
| patient and professional communications | 22% | 28% | 27% |
| professional learning and development | 19% | 23% | 23% |
| healthcare systems and health economics | 19% | 20% | 21% |
| evidence-based decision making | 18% | 18% | 18% |
| quality improvement | 11% | 17% | 17% |
| healthcare education | 16% | 17% | 16% |
| pharmacoepidemiology | 12% | 13% | 14% |
| health advocacy | 15% | 14% | 14% |
| biostatistics | 15% | 14% | 13% |
| health equity and social determinants of health | 9% | 13% | 12% |
| ethical and professional standards of practice | 8% | 10% | 11% |
| pharmacoeconomics | 8% | 10% | 10% |
| professional identity formation | 10% | 9% | 10% |
| critical appraisal of medical literature | 9% | 9% | 9% |
| public health | 2% | 8% | 8% |
| Indigenous history (residential schools, colonialism), anti-Indigenous racism, right to self-determination, values, teachings, practices, and healthcare needs | 2% | 7% | 8% |
| patient safety | 6% | 8% | 8% |
| drug information provision | 5% | 7% | 7% |
| collaborative care and shared decision-making | 6% | 7% | 6% |
| health systems planning | 17% | 5% | 5% |
| cultural safety, humility, and responsiveness | 8% | 5% | 4% |
| digital health | 5% | 5% | 4% |
| dispensing and prescription processing | 3% | 3% | 3% |
| professional wellbeing | 7% | 5% | 2% |
| cultural diversity | 1% | 2% | 2% |
| patient assessment/pharmacotherapy work-up | 1% | 2% | 2% |
| pharmacist patient care process | 1% | 2% | 2% |
| climate change and its effects on health | 3% | 1% | 1% |
| substance use disorders, dependency, and addiction | 2% | 1% | 1% |
| best possible medication history and medication reconciliation | 1% | 1% | 1% |
| collection of patient data | 3% | 1% | 1% |
| documentation of care | 3% | 1% | 1% |
| global citizenship | — | — | 1% |
| virtual care provision | 2% | — | — |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
The two streams share documented learning around pharmacy law/regulatory issues, evidence-based practice, and medication safety/medication‑use processes across Years 1–3. BASE frames this territory in terms of patient‑centred communication, medication‑use workflow, monitoring/adherence, health systems and professional roles. Pharmaceutical Sciences documents related foundational content in pharmacology, pharmaceutics, pharmacokinetics and toxicology that connects to drug effects, dosing and safety; intersection records additionally show overlapping mappings in legal/regulatory topics and pharmacoepidemiology.
Practice Skills
Patient care, communication and applied practice
BASE and Practice Skills share documented learning around patient and professional communication, patient assessment/pharmacotherapy work‑up, evidence‑based decision making, pharmacy law/regulatory topics, and professional learning/leadership across Years 1–3. This relationship is supported by course‑level outcomes, session topic lists, assessment descriptors/weights, and CCAPP/AFPC mapping compositions provided in the supplied materials for the 2023–2024 cycle.
Therapeutics
Therapeutic decision-making and clinical application
BASE shares documented learning around patient and professional communication, patient assessment/pharmacotherapy work‑up, evidence‑based decision making and drug information provision that are adjacent to Therapeutics’ clinical content. Across Years 1–3 the supplied course outcomes, session lists and framework mappings also show overlapping coverage in patient safety, quality improvement, healthcare systems/public health, cultural safety/Indigenous health, and health advocacy.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
Instruction is organized around frequent short, lecture-driven sessions supplemented by longer seminar/case blocks and project lab time. Students receive foundational content in 50‑minute lectures and then apply knowledge in 110‑minute seminars that use active learning, team-based tasks and case discussion. Distinctive student activities include small-group team problem solving (TBL/PBL) in seminars, communication skills practice and role-play, evidence‑appraisal workshops, and multi-session team projects with scheduled open project time and instructor support. Occasional assessments include midterms and a mix of in‑class reviews.
Documented delivery mix
215Lecture
37Seminar
5Lab
9Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 89
2024-2025n = 89
2023-2024n = 89
Year 2
2025-2026n = 99
2024-2025n = 87
2023-2024n = 87
Year 3
2025-2026n = 100
2024-2025n = 90
2023-2024n = 90
How learning is assessed
Students are expected to demonstrate factual knowledge retrieval, applied problem solving, evidence appraisal and professional participation. Assessment consistently elicits these performances through high‑stakes computer‑based midterms and finals alongside frequent low‑stakes quizzes that check pre‑class preparation. Deeper application and communication are assessed with written evidence‑appraisal assignments, implementation‑style projects and short presentations; teamwork and peer evaluation are used to capture collaborative skills. Regular seminar attendance and brief reflective submissions provide formative checks on professional engagement. The overall pattern mixes large summative exams with targeted applied written and oral tasks.
Assessment pattern
13Quiz
8Assignment/written work
5Final exam
4Midterm exam
4Other/unspecified
- Quiz
- Assignment/written work
- Final exam
- Midterm exam
- Other/unspecified
- Other
Year 1
2025-2026n = 10
2024-2025n = 9
2023-2024n = 9
Year 2
2025-2026n = 10
2024-2025n = 12
2023-2024n = 13
Year 3
2025-2026n = 17
2024-2025n = 14
2023-2024n = 14
Overall focus
The BASE stream covers pharmacist professional role and professionalism, patient‑centred communication, medication‑use processes, evidence‑based practice methods, social determinants and Indigenous health across Years 1–3. Skills include assessment, evidence appraisal and educational/negotiation design; attitudes address self‑awareness and responsibility for professional development, with course outcomes spanning community and system contexts.
Development across years
Documented learning emphasis moves from foundational communication, identity and medication‑use basics in Year 1 to applied appraisal, hospital/management processes and medication‑safety practices in Year 2, and toward system‑level advocacy, leadership, implementation/evaluation planning and culturally safe communication in Year 3, as reflected in mappings and assessment shifts.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The BASE curriculum across Years 1–3 integrates behavioural, administrative, social and evidence‑based pharmacy. Documented outcomes cover pharmacist professionalism and patient‑centred communication, medication‑use and safety, jurisprudence and regulatory frameworks, evidence‑based practice and information mastery, health systems and informatics, Indigenous health and social determinants, quality improvement methods, education design, negotiation, leadership and service evaluation. Design and evaluation of new patient‑care services and program evaluation appear as culminating work.
49Documented learning outcomes
246Documented topics
7AFPC roles represented
35CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
Outcomes show a balance of applied skills (communication, assessment, education design, quality improvement) and knowledge (regulatory frameworks, evidence methods, systems), with attitudes documented around professionalism and lifelong learning.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 18
2024-2025n = 17
2023-2024n = 17
Year 2
2025-2026n = 17
2024-2025n = 16
2023-2024n = 15
Year 3
2025-2026n = 16
2024-2025n = 16
2023-2024n = 16
AFPC professional roles
AFPC mappings are dominated by Scholar, Professional and Leader‑Manager roles, documenting curriculum attention to scholarly reasoning, professional responsibilities and management/leadership competencies across the stream.
- Scholar
- Professional
- Leader-Manager
- Health Advocate
- Care Provider
- Other
Year 1
2025-2026n = 121
2024-2025n = 118
2023-2024n = 121
Year 2
2025-2026n = 138
2024-2025n = 119
2023-2024n = 120
Year 3
2025-2026n = 130
2024-2025n = 115
2023-2024n = 115
CCAPP curriculum topics
CCAPP topic composition highlights pharmacy law and regulatory issues, management and leadership, research methods, and patient/professional communications — indicating curriculum emphasis on legal/regulatory knowledge, organizational skills, research literacy and clinician communication.
- pharmacy law and regulatory issues
- management and leadership
- research methods
- patient and professional communications
- professional learning and development
- Other
Year 1
2025-2026n = 121
2024-2025n = 118
2023-2024n = 121
Year 2
2025-2026n = 138
2024-2025n = 119
2023-2024n = 120
Year 3
2025-2026n = 130
2024-2025n = 115
2023-2024n = 115
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 194 | 2024-2025 n = 176 | 2023-2024 n = 179 |
|---|---|---|---|
| pharmacy law and regulatory issues | 44% | 42% | 43% |
| management and leadership | 47% | 39% | 40% |
| research methods | 36% | 33% | 33% |
| patient and professional communications | 22% | 28% | 27% |
| professional learning and development | 19% | 23% | 23% |
| healthcare systems and health economics | 19% | 20% | 21% |
| evidence-based decision making | 18% | 18% | 18% |
| quality improvement | 11% | 17% | 17% |
| healthcare education | 16% | 17% | 16% |
| health advocacy | 15% | 14% | 14% |
| biostatistics | 15% | 14% | 13% |
| pharmacoepidemiology | 12% | 13% | 14% |
| health equity and social determinants of health | 9% | 13% | 12% |
| pharmacoeconomics | 8% | 10% | 10% |
| ethical and professional standards of practice | 8% | 10% | 11% |
| professional identity formation | 10% | 9% | 10% |
| critical appraisal of medical literature | 9% | 9% | 9% |
| public health | 2% | 8% | 8% |
| patient safety | 6% | 8% | 8% |
| Indigenous history (residential schools, colonialism), anti-Indigenous racism, right to self-determination, values, teachings, practices, and healthcare needs | 2% | 7% | 8% |
| collaborative care and shared decision-making | 6% | 7% | 6% |
| drug information provision | 5% | 7% | 7% |
| health systems planning | 17% | 5% | 5% |
| professional wellbeing | 7% | 5% | 2% |
| cultural safety, humility, and responsiveness | 8% | 5% | 4% |
| digital health | 5% | 5% | 4% |
| dispensing and prescription processing | 3% | 3% | 3% |
| cultural diversity | 1% | 2% | 2% |
| patient assessment/pharmacotherapy work-up | 1% | 2% | 2% |
| pharmacist patient care process | 1% | 2% | 2% |
| climate change and its effects on health | 3% | 1% | 1% |
| substance use disorders, dependency, and addiction | 2% | 1% | 1% |
| collection of patient data | 3% | 1% | 1% |
| documentation of care | 3% | 1% | 1% |
| best possible medication history and medication reconciliation | 1% | 1% | 1% |
| virtual care provision | 2% | — | — |
| global citizenship | — | — | 1% |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
Across the 2024–2025 cycle the streams share documented learning around pharmacy law/regulatory issues, research methods/evidence appraisal, and medication‑related safety topics. BASE emphasizes applied competencies—communication, medication‑use processes, monitoring, quality improvement, advocacy and service implementation—across Years 1–3. Pharmaceutical Sciences documents foundational disciplinary topics (pharmaceutics, pharmacology, pharmacokinetics and toxicology) and scientific methods that connect to dosing, formulation, interpretation of evidence and toxicologic management; recorded intersections include multiple regulatory and pharmacoepidemiology mappings.
Practice Skills
Patient care, communication and applied practice
Across Years 1–3 BASE and Practice Skills share documented learning territory in patient and professional communication, patient assessment/pharmacotherapy work‑up, evidence‑based decision making, law/regulatory content and leadership/management topics. The relationship is supported by course‑level outcomes, session inventories and topics, assessment weightings and the CCAPP/AFPC mapping compositions provided for 2024–2025.
Therapeutics
Therapeutic decision-making and clinical application
Across Years 1–3 BASE shares documented learning around patient and professional communications, patient assessment/pharmacotherapy work‑up, evidence‑based decision making and drug information provision that relate to Therapeutics’ clinical content. The documented materials also show overlapping emphasis on healthcare systems/public health, patient safety and quality improvement, cultural safety/Indigenous health, leadership/management and health advocacy across the three years.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
Learning is arranged as a mix of concise lecture input and longer applied seminars, with active learning and team tasks interwoven. Students receive core content in brief lectures and then practice application in longer case/seminar sessions, negotiation and evidence‑appraisal workshops, and project planning blocks. Distinctive activities across the stream include hospital site or partner interactions, seminar‑based evidence appraisal, team planning for implementation projects, and occasional recorded or distance assessments and reviews.
Documented delivery mix
215Lecture
37Seminar
5Lab
9Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 89
2024-2025n = 89
2023-2024n = 89
Year 2
2025-2026n = 99
2024-2025n = 87
2023-2024n = 87
Year 3
2025-2026n = 100
2024-2025n = 90
2023-2024n = 90
How learning is assessed
Students are expected to demonstrate core knowledge, apply evidence to problems, plan interventions, and participate professionally. Assessment commonly combines proctored multiple‑choice midterms and finals with recurring short online quizzes that check pre‑class preparation. Applied competencies are elicited through written evidence‑based assignments, implementation or advocacy projects, and brief oral presentations; peer evaluation captures teamwork contributions. Seminar attendance and small participation tasks provide ongoing formative signals of engagement and professional behaviour.
Assessment pattern
12Quiz
8Assignment/written work
5Final exam
4Midterm exam
4Other/unspecified
- Quiz
- Assignment/written work
- Final exam
- Midterm exam
- Other/unspecified
- Other
Year 1
2025-2026n = 10
2024-2025n = 9
2023-2024n = 9
Year 2
2025-2026n = 10
2024-2025n = 12
2023-2024n = 13
Year 3
2025-2026n = 17
2024-2025n = 14
2023-2024n = 14
Overall focus
The BASE stream documents professional role formation, patient‑centred communication, social determinants and Indigenous awareness, jurisprudence, patient safety, health informatics, evidence‑based practice and basic biostatistics across Years 1–3. Skills include critical appraisal, documentation, dispensing foundations, and service‑design planning; attitudes include inclusivity, reflective practice and commitment to ongoing professional development.
Development across years
Documented emphasis shifts from foundational professional identity, communication and early evidence‑literacy in Year 1 to stronger evidence/scholarship and system analysis in Year 2, then toward leadership, advocacy and service‑design/application in Year 3, with later years showing increased project/experiential time and assessment weight on implementation and team projects.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The BASE stream documents foundational and applied behavioural, administrative, social and evidence‑based pharmacy across three years. Outcomes enumerate pharmacist professional role, patient‑centred communication and assessment, evidence appraisal (RCTs, non‑inferiority, systematic reviews), basic biostatistics and pharmacoepidemiology, jurisprudence and regulatory frameworks, informatics and drug information, quality improvement and patient safety practices, and advanced leadership, implementation and evaluation planning for new pharmacy services including business and program evaluation skills.
51Documented learning outcomes
257Documented topics
7AFPC roles represented
36CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
Documented KSA composition lists knowledge and skills as co‑dominant (knowledge slightly higher), with attitudes present and focused on professional development, cultural humility and reflective practice.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 18
2024-2025n = 17
2023-2024n = 17
Year 2
2025-2026n = 17
2024-2025n = 16
2023-2024n = 15
Year 3
2025-2026n = 16
2024-2025n = 16
2023-2024n = 16
AFPC professional roles
AFPC mappings show a strong Scholar presence with substantial Leader‑Manager and Professional mappings, documenting focus on scholarly reasoning, leadership/management capabilities and professional accountability in the curriculum.
- Scholar
- Leader-Manager
- Professional
- Health Advocate
- Care Provider
- Other
Year 1
2025-2026n = 121
2024-2025n = 118
2023-2024n = 121
Year 2
2025-2026n = 138
2024-2025n = 119
2023-2024n = 120
Year 3
2025-2026n = 130
2024-2025n = 115
2023-2024n = 115
CCAPP curriculum topics
CCAPP top topics include management and leadership, pharmacy law/regulatory issues, research methods, patient/professional communications and healthcare systems — documenting curricular emphasis on governance, law, evidence methods and communication for pharmacy practice.
- management and leadership
- pharmacy law and regulatory issues
- research methods
- patient and professional communications
- healthcare systems and health economics
- Other
Year 1
2025-2026n = 121
2024-2025n = 118
2023-2024n = 121
Year 2
2025-2026n = 138
2024-2025n = 119
2023-2024n = 120
Year 3
2025-2026n = 130
2024-2025n = 115
2023-2024n = 115
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 194 | 2024-2025 n = 176 | 2023-2024 n = 179 |
|---|---|---|---|
| management and leadership | 47% | 39% | 40% |
| pharmacy law and regulatory issues | 44% | 42% | 43% |
| research methods | 36% | 33% | 33% |
| patient and professional communications | 22% | 28% | 27% |
| healthcare systems and health economics | 19% | 20% | 21% |
| professional learning and development | 19% | 23% | 23% |
| evidence-based decision making | 18% | 18% | 18% |
| health systems planning | 17% | 5% | 5% |
| healthcare education | 16% | 17% | 16% |
| health advocacy | 15% | 14% | 14% |
| biostatistics | 15% | 14% | 13% |
| pharmacoepidemiology | 12% | 13% | 14% |
| quality improvement | 11% | 17% | 17% |
| professional identity formation | 10% | 9% | 10% |
| critical appraisal of medical literature | 9% | 9% | 9% |
| health equity and social determinants of health | 9% | 13% | 12% |
| ethical and professional standards of practice | 8% | 10% | 11% |
| pharmacoeconomics | 8% | 10% | 10% |
| cultural safety, humility, and responsiveness | 8% | 5% | 4% |
| professional wellbeing | 7% | 5% | 2% |
| patient safety | 6% | 8% | 8% |
| collaborative care and shared decision-making | 6% | 7% | 6% |
| drug information provision | 5% | 7% | 7% |
| digital health | 5% | 5% | 4% |
| dispensing and prescription processing | 3% | 3% | 3% |
| collection of patient data | 3% | 1% | 1% |
| documentation of care | 3% | 1% | 1% |
| climate change and its effects on health | 3% | 1% | 1% |
| Indigenous history (residential schools, colonialism), anti-Indigenous racism, right to self-determination, values, teachings, practices, and healthcare needs | 2% | 7% | 8% |
| substance use disorders, dependency, and addiction | 2% | 1% | 1% |
| public health | 2% | 8% | 8% |
| virtual care provision | 2% | — | — |
| patient assessment/pharmacotherapy work-up | 1% | 2% | 2% |
| pharmacist patient care process | 1% | 2% | 2% |
| cultural diversity | 1% | 2% | 2% |
| best possible medication history and medication reconciliation | 1% | 1% | 1% |
| global citizenship | — | — | 1% |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
Across 2025–2026 the streams share documented learning around pharmacy law/regulatory issues, ethical/professional standards, patient assessment/pharmacotherapy work‑up, and substance‑use/toxicology topics in later years. BASE frames this territory in applied terms—communication, medication‑use processes, monitoring, quality improvement, advocacy and service implementation across Years 1–3. Pharmaceutical Sciences frames complementary documented territory in pharmaceutics, pharmacology, pharmacokinetics and toxicology that connects to drug action, dosing, compounding and toxicologic recognition; the packet records multiple overlapping mappings in regulatory, ethical and substance‑use domains.
Practice Skills
Patient care, communication and applied practice
Across Years 1–3 BASE and Practice Skills share documented curricular territory in patient and professional communication, patient assessment and care planning, evidence‑based decision making and appraisal, pharmacy law/regulatory topics, and leadership/management and advocacy. The supplied materials for 2025–2026 (course outcomes, session/topic inventories, assessment listings and CCAPP/AFPC mappings) document these overlapping areas across the three program years.
Therapeutics
Therapeutic decision-making and clinical application
Across Years 1–3 BASE shares documented learning around pharmacy law and regulatory issues, patient and professional communication, evidence‑based decision making and drug information provision that relate to Therapeutics’ clinical content. The supplied mappings and course/session summaries also indicate overlapping emphasis on leadership/management, healthcare systems and economics, quality improvement, public health and health advocacy across the three years.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
Instruction is delivered primarily in person through lectures and seminar/case sessions, supplemented by site visits, asynchronous lectures, and project open time. Students receive concentrated lecture content and then apply it in seminars, hospital pharmacy site visits, evidence‑appraisal debriefs, and project development meetings. Distinctive activities include multi‑slot hospital pharmacy site visits for firsthand observation, peer‑assisted learning sessions, seminar debriefs of applied cases, and instructor‑supported project work.
Documented delivery mix
218Lecture
37Seminar
5Lab
28Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 89
2024-2025n = 89
2023-2024n = 89
Year 2
2025-2026n = 99
2024-2025n = 87
2023-2024n = 87
Year 3
2025-2026n = 100
2024-2025n = 90
2023-2024n = 90
How learning is assessed
Students are expected to demonstrate secure content knowledge under time pressure, evidence‑based appraisal, team‑based planning, and professional behaviours. The characteristic assessment mix pairs proctored closed‑book computer exams (MCQ and short answer) with timed open‑book quizzes for incremental checks. Applied competence is elicited through multi‑part evidence assignments (completion and scored components), team implementation projects with oral presentations and rubrics, and mandatory seminar/site‑visit activities. Peer evaluation and short reflective tasks capture teamwork and professional judgment.
Assessment pattern
11Assignment/written work
9Participation/professionalism
8Quiz
5Final exam
4Midterm exam
- Assignment/written work
- Participation/professionalism
- Quiz
- Final exam
- Midterm exam
Year 1
2025-2026n = 10
2024-2025n = 9
2023-2024n = 9
Year 2
2025-2026n = 10
2024-2025n = 12
2023-2024n = 13
Year 3
2025-2026n = 17
2024-2025n = 14
2023-2024n = 14
Explore the Curriculum
What curriculum records sit behind this overview?
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 212 — PHARM 212 - BASE 1 | Y1 | Fall | 38 | 6 | 0 | Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | — |
| PHARM 213 — PHARM 213 - BASE 2 | Y1 | Winter | 37 | 6 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Other/unspecified (1); Quiz (1) | — |
| PHARM 312 — PHARM 312 - BASE 3 | Y2 | Fall | 34 | 7 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Other/unspecified (1); Quiz (1) | — |
| PHARM 313 — PHARM 313 - BASE 4 | Y2 | Winter | 38 | 6 | 0 | Final exam (1); Midterm exam (1); Quiz (6) | — |
| PHARM 412 — PHARM 412 - BASE 5 | Y3 | Fall | 35 | 6 | 0 | Assignment/written work (2); Final exam (1); Participation/professionalism (1); Quiz (1) | — |
| PHARM 413 — PHARM 413 - BASE 6 | Y3 | Winter | 33 | 6 | 5 | Assignment/written work (4); Other/unspecified (2); Quiz (3) | — |
Session Information
| PHARM 212 | Y1 | Fall | 2023-09-06 | Lecture | Intro to BASE | BASE - Intro: Structure, Theory, and Model of BASE | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-09-08 | Lecture | The Profession of Pharmacy | Administration - Role: profession, professionalism, professional identity. | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-09-11 | Lecture | Regulatory Framework | Administration - Jurisprudence: Introduction to the legislative framework that governs pharmacy practice; Legislation - federal, provincial, ACP | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-09-12 | Seminar/case session | Seminar 1: Pharmacist's Role | Administration - Jurisprudence: Team Rules, Expectations, and Logo, Professionalism Case Studies | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-09-13 | Lecture | Patient Assessment | Collecting appropriate information; documenting appropriate information | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-09-15 | Lecture | Medication Use Process - Dispensing - Part 1 | Describe how the medication use process intersects with the patient care process; Describe the regulatory requirements of a prescription with the medication use process; Apply the steps of the dispensing process to fill a prescription | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-09-18 | Lecture | Medication Use Process - Dispensing - Part 2 | Describe how the medication use process intersects with the patient care process; Describe the regulatory requirements of a prescription with the medication use process; Apply the steps of the dispensing process to fill a prescription | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-09-20 | Lecture | Core Communication Skills | Listening, Question Asking, Non-verbal Communication, Probes; | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-09-22 | Lecture | Medication Experience | Social - Med Exp: power/privilege, iatrogenesis, medicalization, medical gaze, medication experiences | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-09-25 | Lecture | Gathering a Focused Patient History | Behaviour - Comm Focused Hx: Building rapport, agenda setting, flexible structure, managing time | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-09-26 | Seminar/case session | Seminar 2: Core Communication Skills | Behaviour - Comm: listening, empathy | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-09-27 | Lecture | Building Relationships | Social - History: Pharmacist Contributions to Society and the World | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-09-29 | Lecture | Medication Monitoring | Questions asking, non-adherence, direct and non-threatening strategies | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-10-02 | Lecture | Communicating with Emotional Patients | Behaviour - Comm Emotional: Communicating with Emotional Patients | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-10-04 | Lecture | Documenting Prescription Order Activities - Part 1 | Apply communication techniques (NOD and SBAR) when clarifying and / or requesting information pertaining to a prescription | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-10-06 | Lecture | Documenting Prescription Order Activities - Part 2 | Differentiate the requirements of written, verbal, faxed and e-prescriptions; Demonstrate how to transfer and how to receive a transfer of a prescription | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-10-11 | Lecture | Practice Expectations | Identify practice expectations of pharmacists defined through the practice framework; Describe the role of pharmacists and restricted activities we perform | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-10-13 | Lecture | Introduction to the BASE Evidence Stream | Evidence - EBM: Overview of BASE Evidence Curriculum, (Evidence Based Clinical Practice, Drug Information, & Health Informatics | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2023-10-16 | Lecture | Introduction to Evidence Based Clinical Practice | Evidence - EBM: Intro to Evidence Based Clinical Practice | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2023-10-17 | Seminar/case session | Seminar 3: Drug Information Resources | Evidence - EBM: -Evaluating the credibility of online health/drug/pharmacy resources; Finding/Using Summary Resources | J. Kung |
| PHARM 212 | Y1 | Fall | 2023-10-18 | Lecture | Introduction to Drug Information | Evidence - EBM: Defining Information Resources | K. Sorensen |
| PHARM 212 | Y1 | Fall | 2023-10-20 | Lecture | Drug Information Resources | Evidence - EBM: Systematic Approach to Answering (Drug Information) Questions | K. Sorensen |
| PHARM 212 | Y1 | Fall | 2023-10-23 | Lecture | Systematic Approach to Drug Information | Evidence - EBM: Introduction to Summary Resources: Systematic Reviews/Meta-Analysis | K. Sorenson |
| PHARM 212 | Y1 | Fall | 2023-10-25 | Lecture | Information Mastery, Using Information Resources at the Point of Care | Evidence - EBM: Systematic Approach to Answering (Drug Information) Questions | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2023-10-27 | Midterm exam | Midterm | MIDTERM | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-10-30 | Lecture | Accessing High Quality Evidence in Practice: Overview of the 6S Approach | Evidence - EBM: Information Management: Using Information Resources at the Point of Care | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2023-10-31 | Seminar/case session | Seminar 4: Equity, Diversity, Inclusivity - Practice expectations | Review of EDI principles with a focus on racism within the pharmacy space | N. Austin-Bishop, J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-11-01 | Lecture | Clinical Practice Guidelines 101 | Evidence - EBM: Information Management: Overview of the 6S approach | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2023-11-03 | Lecture | Systematic Reviews 101 | Evidence - EBM: Introduction to Summary Resources: Clinical Practice Guidelines | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2023-11-06 | Lecture | Prescription drug pricing and Insurance model for prescription drug benefits | Calculate the cost of prescription medications in a community pharmacy practice setting in Alberta; Determine how insurance for prescription drug benefits impacts patients’ medication costs | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-11-08 | Lecture | Alberta Government Sponsored Drug Benefit Plans | Differentiate the government sponsored Alberta Blue Cross drug plans; Describe the Alberta Drug Benefit List and Alberta Drug Benefit Supplement; Apply principles of the iDBL to prescription pricing; Describe the Special Authorization process administered by Alberta Blue Cross | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-11-10 | Lecture | Other Drug Benefit Plans | Federal and Privately Administered Drug Plans | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-11-15 | Lecture | Ethics and the pharmacy profession | Administration - Ethics: Introduction to the ACP Code of Ethics beneficence, nonmaleficence, autonomy, and informed consent | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-11-17 | Lecture | Professional Discipline Process (ACP) | Administration - Ethics: Discipline process, Mitigating errors | J. Krempien |
| PHARM 212 | Y1 | Fall | 2023-11-20 | Lecture | Overview of Substance Abuse by Pharmacists | Administration - Ethics: substance abuse, misuse, incapacity, diversion and trafficking | J. Krempien |
| PHARM 212 | Y1 | Fall | 2023-11-21 | Seminar/case session | Seminar 5: Ethical principles in practice | Argue both sides of an ethical issue using ethical principles from the Alberta College of Pharmacy's Code of Ethics | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-11-22 | Lecture | How can sociology help pharmacists? | Social - Soc -Intro: Psychosocial perspectives on medication use | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-11-24 | Lecture | Medication Taking Theory | Social - Med Taking: Theory of Adherence vs. Compliance, Intelligent Noncompliance, Necessity-Concerns Framework | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2023-11-27 | Lecture | Social Determinants of Health (SDoH) | Social - SDoH: social determinants of health, health equity, health disparities, health equities, social gradient, health in all policies | K. Watson |
| PHARM 212 | Y1 | Fall | 2023-11-29 | Lecture | Social Determinants of Health (SDoH) | Social - SDoH: 14 Social determinants of health, Poverty: A clinical tool for primary care providers | K. Watson |
| PHARM 212 | Y1 | Fall | 2023-12-01 | Lecture | Indigenous Health and Pharmacy | Social - Indigenous: Indigenous terminology, myths, Indian Status in Canada, We-are-Treaty People | A. Ruben |
| PHARM 212 | Y1 | Fall | 2023-12-04 | Lecture | Indigenous Health and Pharmacy | Social - Indigenous: Indigenous Health Issues: clean water, safe housing, and support families, Discrimination in health care, Brain Sinclar story | A. Ruben |
| PHARM 212 | Y1 | Fall | 2023-12-05 | Seminar/case session | Seminar 6: The Unforgotten Toolkit: An Educational Guide to Learn about, Reflect on and Dismantle Anti-Indigenous Racism in Health Care | Describe the connection between historical and current government practices towards Indigenous Peoples (including; but not limited to colonization, residential schools; treaties and land claims), and the resultant intergenerational health outcomes. | A. Ruben |
| PHARM 212 | Y1 | Fall | 2023-12-06 | Lecture | Non-Insured Health Benefits (NIHB) | Describe Non-Insured Health Benefits (NIHB) program; Assess eligibility for NIHB benefits; Navigate the NIHB Drug Benefit List; Apply principles of NIHB coverage to patient cases | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2023-12-08 | Lecture | Wrap-Up Lecture | BASE - Wrap-Up, Course Evaluation | BASE Team |
| PHARM 213 | Y1 | Winter | 2024-01-08 | Lecture | Health Literacy I | Behaviour - Health literacy criteria, identification, strategies | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-01-10 | Lecture | Health Literacy II | Behaviour - Health literacy | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-01-12 | Lecture | Individual Patient Education | Behaviour - Educational strategies - verbal and written; tailoring, readability, chunking, teach-back | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-01-15 | Lecture | Written Materials | Behaviour - Plain language and readability | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-01-16 | Seminar/case session | Educational Materials Seminar | Behaviour - Teach-back | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-01-17 | Lecture | Communicating Risk About Medications | Behaviour - Visual/oral communication; palling palettes, odds, direction | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-01-19 | Lecture | Patient-Centred Interviewing | Patient-Centred Interviewing | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-01-22 | Lecture | Introduction to Jurisprudence & Federal Jurisprudence I | Administration - Food and Drugs Act/Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-01-24 | Lecture | Federal Jurisprudence II | Administration - Food and Drugs Act/Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-01-26 | Lecture | Federal Jurisprudence III | Administration - Controlled Drugs and Substances Act/Regulations/Schedules | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-01-29 | Lecture | Federal Jurisprudence IV | Administration - Part G & J of the Food and Drugs Act/Tracked Prescription Program | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-01-30 | Seminar/case session | Tracked Prescription Program Seminar | Administration - Narcotic Regulation Practice Cases, Administration - Tracked Prescription Program | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-01-31 | Lecture | Drug Diversion and Robbery Prevention | Administration - Drug Diversion and Robbery Prevention Techniques | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-02 | Lecture | Provincial Jurisprudence I | Administration - Health Professions Act/Pharmacy and Drug Act | G. Eberhart, D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-05 | Lecture | Provincial Jurisprudence II | Administration - Health Information Act | G. Eberhart, D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-07 | Lecture | Provincial Jurisprudence III | Administration - ACP Guidance | G. Eberhart/D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-08 | Lecture | Health Canada Vigilance Program | Administration - Health Canada Vigilance Program and ADR Reporting | K. Popovic |
| PHARM 213 | Y1 | Winter | 2024-02-09 | Lecture | Drug Scheduling | Administration - Drug Scheduling | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-12 | Lecture | Jurisprudence Application | Administration - Drug Scheduling Application, Administration - Legislation Application | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-13 | Seminar/case session | Jurisprudence Seminar | Administration - Jurisprudence Jeopardy/Midterm Review | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-16 | Lecture | Additional Jurisprudence Topics | Administration - Other HCP Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-26 | Lecture | ACP Standards of Practice | Administration - ACP Standards of Practice, Administration - Pharmacist Prescribing | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-02-28 | Lecture | Fostering a Culture of Patient Safety | Administration - Patient Safety | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-03-01 | Lecture | Disclosure of Medical Errors | Behaviour - Strategies for disclosing errors | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-03-04 | Lecture | Evidence Literacy | Evidence - Reading a trial, synopsis | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-05 | Seminar/case session | Finding Studies & Synopses | Evidence - Evidence Literacy Seminar | J. Kung/M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-06 | Lecture | Evidence and Drug Development | Evidence - Drug policy and review process | S. Alsaadi |
| PHARM 213 | Y1 | Winter | 2024-03-07 | Lecture | Trial Designs | Evidence - Overview of experimental and observational designs & introduction to RCTs | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-08 | Lecture | Study Results I | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-11 | Lecture | Study Results II | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-13 | Lecture | Study Results III | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-15 | Lecture | Confidence Intervals | Evidence - Confidence Intervals | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-18 | Lecture | Measuring Patient Experiences | Evidence - Continuous data (Scales); Comparison of 2 Means; Comparison of 2 Proportions; Power and Sample Size | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-19 | Seminar/case session | Journal Club Seminar | Evidence - Topics listed on eClass | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-20 | Lecture | Time to Event Outcomes, Survival Analysis, & Hazard Ratios | Evidence - Hazard Ratios, time to event, and survival analysis | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-22 | Lecture | Meta Analysis Results | Evidence - Forest plot, pooled OR, SMD, WMD | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2024-03-25 | Lecture | Community Site Visit Debrief | Behaviour - Professional Identity Formation (PIF) | J. Hall/J. Shkrobot |
| PHARM 213 | Y1 | Winter | 2024-03-27 | Lecture | Leading Self | Behaviour - Leading Self | T. Makhinova |
| PHARM 213 | Y1 | Winter | 2024-04-02 | Seminar/case session | Leading Self Seminar | Behaviour - Leading Self | T. Makhinova |
| PHARM 213 | Y1 | Winter | 2024-04-03 | Lecture | Talking About Change: Smoking Cessation | Behaviour - Transtheoretical Model | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-04-05 | Lecture | Leadership/Continuing Professional Development | Behaviour - Leadership, CPD | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-04-08 | Lecture | Continuing Professional Development | Behaviour - CPD Process, ACP Continuing Competence Program | D. Moulton |
| PHARM 213 | Y1 | Winter | 2024-04-10 | Lecture | Communicating with Children | Behaviour - Communicating with children | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2024-04-12 | Final exam | BASE Wrap-Up, SPoT Survey, & Final Exam Review | BASE - Review, wrap up | All Lecturers |
| PHARM 312 | Y2 | Fall | 2023-09-06 | Lecture | Course Introduction & Healthcare Resources | Canada Health Act, Accreditation Canada, College of Physicians & Surgeons of Alberta, Patient & Public Involvement in Healthcare, Cost of Healthcare resources | J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2023-09-06 | Lecture | Lecture 1- Course Introduction | Course Intro | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-09-08 | Lecture | Provision of Healthcare Services | Public Health (PHAC). Emergency Care. Primary/Ambulatory Care. Inpatient/Specialized Care. Homecare. Long-term care. Rehabilitation.Palliative Care. Mental Health. Dental Care. Complementary & Alternative Medicine. First Nations and Inuit Health Services | J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2023-09-11 | Lecture | Health system organizations | Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), Canadian Institute for Health Information (CIHI), Alberta Health (AH), Alberta Health Services (AHS), Health Quality Council of Alberta (HQCA), Canadian Pharmacists Association (CPhA), Neighborhood Pharmacy Association of Canada, Canadian Society of Hospital Pharmacists (CSHP), Alberta College of Pharmacy (ACP), Alberta Pharmacists' Association (RxA) | J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2023-09-13 | Lecture | Medication Use Process in the Hospital Setting | Mission & Vision of AHS Pharmacy Services, Medication Distribution Systems, Automated Dispensing cabinets, Unit Dose, Bulk Tablet Repackaging, Centralized IV Additive Service, Direct Patient Care Service, Medication Safety | K. Olstad |
| PHARM 312 | Y2 | Fall | 2023-09-15 | Lecture | Medication Use Process in the Hospital Setting | Connect Care/EPIC, Medication Reconciliation, Antimicrobial Stewardship, Drugs and Therapeutics Committee, Backorder & Shortage management, Parenteral monographs, Barcoding, Closed Loop medication management | K. Olstad |
| PHARM 312 | Y2 | Fall | 2023-09-18 | Lecture | Leadership: Constructive negotiations | Positional Negotiation, Best Alternative to a Negotiated Agreement, Reservation value, Aspiration value, Zone of possible agreement, Principled negotiation, Failed negotiations | T. Makhinova |
| PHARM 312 | Y2 | Fall | 2023-09-20 | Lecture | How to RELATE and RESPOND to patients in the hospital. | Tips to Interact with Patients & Families in Hospital | L. Guirguis |
| PHARM 312 | Y2 | Fall | 2023-09-21 | Seminar/case session | Constructive Negotiation- Seminar | Positional Negotiation, Principled Negotiation | T. Makhinova |
| PHARM 312 | Y2 | Fall | 2023-09-25 | Lecture | Introduction to the Legal System/The Alberta Court System | Law, Legal system, Institutions of law, Sources of law, Types of legal actions, Canadian Court System, Alberta Court System | M. Yu |
| PHARM 312 | Y2 | Fall | 2023-09-27 | Lecture | Legal Obligations of Regulated Health Care Professionals | Courts vs. Regulators, Regulatory Tools, Professional Liability Insurance, Continuing competence, Breach of Standards of Practice, Drug Diversion, Record Keeping, Character & Reputation | C. Field |
| PHARM 312 | Y2 | Fall | 2023-09-29 | Lecture | Privacy Law (Part 1) | FOIPPA, PIPEDA, CASL, PIPA, HIA, Personal Information, Collection, Use, Disclosure | M. Yu |
| PHARM 312 | Y2 | Fall | 2023-10-02 | Lecture | Privacy Law (Part 2) | Health Information Act- Use, Disclosure, Breach, Compliance | M. Yu |
| PHARM 312 | Y2 | Fall | 2023-10-04 | Lecture | Law of Negligence: Duty & Standard of Care | Torts, Negligence, Duty of care, Standard of care | J. Jackson |
| PHARM 312 | Y2 | Fall | 2023-10-05 | Seminar/case session | Contemporary Issues in Pharmacy Informatics - Seminar | Contemporary Issues in Pharmacy Informatics | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-10-06 | Lecture | Law of Negligence: Causation & Damages | Factual & Legal Causation, Reasonable Foreseeability | J. Jackson |
| PHARM 312 | Y2 | Fall | 2023-10-11 | Lecture | Law of Negligence: Causation & Damages | Damages and forms of compensation, Pecuniary Damages, Non-pecuniary | J. Jackson |
| PHARM 312 | Y2 | Fall | 2023-10-13 | Lecture | Law of Negligence: Defences | Contributory negligence, Voluntary assumption of risk, Illegality, Expiration of time limit for instituting a legal action | J. Jackson |
| PHARM 312 | Y2 | Fall | 2023-10-16 | Lecture | Medical Assistance in Dying: Legal Framework & Role of the Pharmacist | Federal Legislation for MAID, Truchon vs. Procureur, AHS MAID Policy, Track 1 vs. Track 2 | C. Field |
| PHARM 312 | Y2 | Fall | 2023-10-18 | Lecture | Consent and Informed Consent | Voluntary Consent, Capacity (Adults, minors), Elements of Informed Consent | C. Field |
| PHARM 312 | Y2 | Fall | 2023-10-19 | Seminar/case session | Law- Seminar | Negligence, Privacy Law | M. Yu |
| PHARM 312 | Y2 | Fall | 2023-10-20 | Other exam/test | Pharmacogenomic Testing: Ethical and legal considerations | Personalized & Precision Medicine, Fundamentals of Genetics (Genotype, Phenotype), Informed Consent for PGx testing, Privacy, Genetic information Nondiscrimination Act | D. El Sayed |
| PHARM 312 | Y2 | Fall | 2023-10-23 | Lecture | Introduction to Critical Appraisal of a RCT | Assessing Cause & Effect, JAMA Approach to Critical Appraisal of a Therapy Study, Strategies to reduce Bias, Steps to practice EBM, Using Pre-Appraised Resources, Bias & Random Error | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-10-27 | Lecture | Critical Appraisal of a RCT- Assessing Risk of Bias II | Randomization, Allocation concealment, Balancing prognostic factors | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-01 | Seminar/case session | Critical Appraisal of a RCT - Risk of Bias III | Blinding, Loss to followup | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-02 | Seminar/case session | Evidence Appraisal - RCT/NIFT- Seminar | Creating a Study Synopsis, Evidence Appraisal & Application to Patient care | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-03 | Lecture | Critical Appraisal of a RCT - Risk of Bias IV | Intention to Treat Analysis, Per Protocol Analysis, On Treatment analysis, Stopping Rules, Funding Bias | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-06 | Lecture | Critical Appraisal of a RCT - Study Results & Application to patient care | Magnitude & Precision of Effect, Internal & External validity, Subgroup analysis, Drug Class effects, Surrogate vs. Patient Important Outcomes, Composite Endpoints, Personalizing Risks & Benefit Information for Individual Patients. | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-08 | Lecture | Evaluation & Application of Systematic Reviews - Part 1: Search and Selection | Systematic Review, Meta analysis, Review Registration, PRISMA, Characteristics of a Credible review, Heterogeneity | S. Simpson |
| PHARM 312 | Y2 | Fall | 2023-11-10 | Lecture | Evaluation & Application of Systematic Reviews – Part 2: Data Abstraction and Analysis | Risk of BIas Assessment, Publication Bias, Sensitivity Analysis, Assessment of Heterogeneity, Fixed & Random Effects Models, Network Meta analysis | S. Simpson |
| PHARM 312 | Y2 | Fall | 2023-11-15 | Lecture | Finding the Best Evidence | Searching at the Point of Care, Systematic Literature Searching, PubMed | J. Kung |
| PHARM 312 | Y2 | Fall | 2023-11-16 | Seminar/case session | Evidence Appraisal - Systematic Reviews - Seminar | Creating a Synopsis, Evidence Appraisal & Application to Patient care | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-17 | Lecture | Critical Appraisal of a Non-Inferiority Trial | Superiority vs. Equivalence, vs. Non-inferiority, JAMA Approach to evaluating Non Inferiority Studies | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-17 | Lecture | Critical Appraisal of a study that measures patient experience | Instruments to measure health status, Attributes of high quality trials assessing health status, Face Validity, Content validity, Construct validity, Reliability, Responsiveness, Precision, Reproducibility, Internal consistency, Interpretability, Minimal Clinically Important Difference | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-21 | Lecture | Critical Appraisal of a Non-Inferiority Trial – Methodological Issues ITT & PPA | Appropriate active control, Appropriate patients & outcomes, Optimal application of treatment regimens, Intention to treat vs. Per Protocol Analysis, Establishing the non inferiority margin, Sample size | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-24 | Lecture | Indigenous Peoples & Access to Pharmacist Care | Health Equity, FNIHB, NIHB Benefit Program | A. Ruben |
| PHARM 312 | Y2 | Fall | 2023-11-27 | Lecture | Indigenous Peoples & Access to Pharmacist Care | Provision of Pharmacy Services to Indigenous Populations | A. Ruben |
| PHARM 312 | Y2 | Fall | 2023-11-29 | Lecture | Hospital Pharmacists' Role as Educator | Skills & Knowledge required to educate groups of patients, Pharmacist experiences in providing group education, Benefits of group education for patients. | T. Schindel |
| PHARM 312 | Y2 | Fall | 2023-11-30 | Seminar/case session | Developing Education Plans for Groups of Patients - Seminar | Creating an Education Plan | T. Schindel |
| PHARM 312 | Y2 | Fall | 2023-12-01 | Lecture | Basics of Learning Theories: Supporting your Role as Educator | Learning Theory; Theoretic frameworks (Behaviorism, humanism, cognitivism, social cognitive, constructivism, critical) | T. Schindel |
| PHARM 312 | Y2 | Fall | 2023-12-04 | Lecture | Designing and Evaluating Education | ADDIE Framework; SMART objectives, Blooms Taxonomy; Formative & Summative Assessment, Program Evaluation | T. Schindel |
| PHARM 312 | Y2 | Fall | 2023-12-08 | Lecture | Wrap Up Lecture: Course Evaluation and Q&A | USRI Course Evaluation, Final Exam Overview, Question & Answer | M. Makowsky |
| PHARM 313 | Y2 | Winter | 2024-01-08 | Lecture | Introduction, Practice shared decision making / risk communication | Behaviour - Shared decision making: Evaluate tools to communicate risk to patients | J. Shkrobot / L. Guirguis |
| PHARM 313 | Y2 | Winter | 2024-01-10 | Lecture | Practice shared decision making / risk communication | Behaviour - Shared decision making: Principles of shared decision making, Comparing shared decision making to traditional communication approaches | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2024-01-11 | Seminar/case session | Shared decision making | Behaviour - Shared decision making: Applying shared decision making principles in patient scenarios | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2024-01-12 | Lecture | Complex Communication - Working with people who have a disability or do not share a common language | Pictograms, Working with a translator; Disability | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2024-01-15 | Lecture | Complex Communication - Facilitating Behaviour Change | Motivational Interviewing | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2024-01-17 | Lecture | Introduction to Pharmacoepidemiology and Limitations of Premarket Evidence | Evidence - Intro to pharmacoepidemiology: Define pharmacoepidemiology terms, Link pharmacoepidemiology and patient care processes | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-01-19 | Lecture | Randomized Controlled Trials and Observational Studies - Why do we need both? | Evidence - Drug approvals: Drug approval process, Pre-marketing clinical trials, resources for decision making, Resources for decision making | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-01-22 | Lecture | Adverse Drug Reaction Reporting and Drug Safety | Evidence - ADR databases: Drug / outcome associations, Spontaneous adverse drug reaction reports and databases, Safety signals | K. Popovic |
| PHARM 313 | Y2 | Winter | 2024-01-24 | Lecture | Common Data Sources Used to Assess Drug Safety and Effectiveness | Evidence - Secondary analysis: Secondary analysis, Prospective cohorts and population based surveys, Data resources for pharmacoepidemiology studies | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-01-25 | Seminar/case session | EBM Seminar 1 - Searching for Drug Safety and Effectiveness Studies | Evidence - Observational research: Finding pharmacoepidemiologic studies to answer patient care questions | J. Kung |
| PHARM 313 | Y2 | Winter | 2024-01-26 | Lecture | Pharmacoepidemiologic Study Designs Part 1: Cross Sectional and Case-Control Studies | Evidence - Pharmacoepidemiology study designs: Cross sectional and case controlled studies, Advantages and limitations of study designs | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-01-29 | Lecture | Pharmacoepidemiologic Study Designs Part 2: Cohort Studies | Evidence - Pharmacoepidemiology study designs: Cohort and nested case control studies, Advantages and limitations of study designs | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-01-31 | Lecture | Defining Variables and Building a Case for Causality | Variable definitions, Causal Interference, Common considerations used in pharmacoepidemiology | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-02-02 | Lecture | Bias in Pharmacoepidemiologic Studies | Evidence - Bias: Strengths and weaknesses of the major observational study designs | D. Nagy |
| PHARM 313 | Y2 | Winter | 2024-02-05 | Lecture | Confounding in Pharmacoepidemiologic Studies | Evidence - Confounding: Confounding and how to minimize its effects in pharmacoepidemiologic studies | D. Nagy |
| PHARM 313 | Y2 | Winter | 2024-02-07 | Lecture | Statistical Analyses in Pharmacoepidemiologic Studies | Common measures of association, Relative, Absolute, Hazard ratio, Common terms in statisical analysis of observational studies, Effect modification and interaction | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-02-08 | Seminar/case session | EBM Seminar 2 - Critical Appraisal of a Pharmacoepidemiologic Study | Evidence - EBM application: Find, evaluate and apply data from pharmacoepidemiologic research to answer patient care questions | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-02-09 | Lecture | Other Applications of Pharmacoepidemiologic Studies | Evidence - Drug utilization: Types of drug utilization studies, their use and intervention strategies | S. Simpson |
| PHARM 313 | Y2 | Winter | 2024-02-12 | Lecture | Evaluating Health Literacy, Patients Centred Care and Medication Taking Behaviours in Pharmacy Organizations | Social - Pharmacy organizations: Health literacy assessment, Organizational health literacy, Measurement, Medication coordination | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2024-02-14 | Lecture | Strategic Planning | Administration - Strategic planning: Strategic planning, SWOT analysis, Competitive strategies, SMART objectives | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-02-16 | Lecture | Change Management | Administration - Change management: Risk of change vs not changing, Kotter's 8-step model of change | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-02-26 | Midterm exam | Midterm Exam | Midterm exam | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-02-28 | Lecture | Planning and implementing patient care services - Part 1 | Administration - Planning patient services: Pharmacy based patient care services, Best practices related to the patient experience, Barriers to new service implementation | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-02-29 | Seminar/case session | Case Studies - Change Management | Administration - Change management: Apply change management strategies to scenarios that may occur within a health team | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-01 | Lecture | Planning and implementing patient care services - Part 2 | Administration - Implementing patient services: Performance measures for patient care services, Implementation plans for patient care services | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-04 | Lecture | Role of Pharmacy Licensee - Part 1 | Administration - Pharmacy Licensee: Regulatory responsibilities of a pharmacy licensee, Comparison of licensee and pharmacist responsibilities | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-06 | Lecture | Role of Pharmacy Licensee - Part 2 | Pharmacy Licensee: Regulatory responsibilities of a pharmacy licensee, Comparison of licensee and pharmacist responsibilities | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-08 | Lecture | Human resource management - Part 1 | Administration - Human resources: Employment legislation, Termination of employment, Union vs non-union employment environments | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-11 | Lecture | Human resource management - Part 2 | Administration - Human resources: Sourcing candidates for employment , Evaluation process for hiring, Negotiation, Orientation / training | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-13 | Lecture | Human resource management - Part 3 | Administration - Human resources: Best practices for HR management, Job descriptions | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-13 | Lecture | Pharmacy Compensation Framework - Part 1 | Alberta's compensation plan for pharmacy services (adaptations, injections, CACP, SMMA), Compensation for services not related to the dispensing of medication | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-14 | Seminar/case session | Case studies - Human resources management | Solve human resource management issues / case studies | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-15 | Lecture | Pharmacy Compensation Framework - Part 2 | Alberta's compensation plan for pharmacy services (adaptations, injections, CACP, SMMA), Compensation for services not related to the dispensing of medication | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-18 | Lecture | Inventory Management | Administration - Inventory management: Principles of inventory management, Sources of supply, Inventory management tools / processes | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-20 | Lecture | Errors in community and hospital settings - Part 1 | Administration - Medication errors: Analyze examples of medication errors | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-22 | Lecture | Errors in community and hospital settings - Part 2 | Administration - Medication errors: Explore mechanisms by which errors can be reduced | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-25 | Lecture | Failure Mode and Effects Analysis | Administration - FMEA: Define FMEA, Apply FMEA in a practice scenario | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-25 | Lecture | Root Cause Analysis | Administration - Root cause analysis: Define the root cause analysis methodology, Apply root cause analysis to practice scenarios | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-27 | Lecture | Risk Management | Administration - Risk management: Types of risk, Risk management plan, Risk management strategies | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-03-28 | Seminar/case session | Peer Assisted Learning | Define the peer learning model and why it works; Discuss the attributes of a good peer to optimize a PAL placement; Practice skills that enable you to be a good peer; Identify activities that can be done with a peer on placement. | A. Thompson, M. MacDonald |
| PHARM 313 | Y2 | Winter | 2024-04-03 | Lecture | Finance - Part 1 | Administration - Finances: Income statement, Balance sheet, Interpretation of financial statements, Gross margin, Gross profit | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-04-05 | Lecture | Finance - Part 2 | Administration - Finances: Cash flow statement, Key financial ratios | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-04-08 | Lecture | Marketing | Administration - Marketing: Marketing concepts, 4 P's, Consumer behaviour, Market segmentation | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2024-04-10 | Lecture | Older Adults, Ageism, and Age Friendly Practice | Social - Pharmacy organizations: Age Friendly Pharmacy, Patient perspectives on pharmacy | C. Sadowski |
| PHARM 313 | Y2 | Winter | 2024-04-12 | Lecture | Wrap Up Lecture | BASE - Review: Wrap Up | BASE Team |
| PHARM 412 | Y3 | Fall | 2022-09-02 | Lecture | Orientation to BASE 5; Health Advocacy in Pharmacy | Social Determinants of Health, Advocacy | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-07 | Lecture | Social Location & Pharmacy | Social Location, Privilege, SDoH | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-09 | Lecture | Critical Reflection in Health Advocacy | Critical Reflection | L. Guiguis |
| PHARM 412 | Y3 | Fall | 2022-09-12 | Lecture | Pharmacist Advocate | Pharmacist Advocate | L.Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-12 | Seminar/case session | Seminar 1: Pharmacist Roles and Community Partner | Advocacy and Community Service Learning; Baseline teamwork | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-14 | Lecture | Patient Advocacy | Patient Advocacy -Patient, Organization, and Society | B.Kidd |
| PHARM 412 | Y3 | Fall | 2022-09-16 | Lecture | Advocacy Approaches | Forms of Advocacy | L.Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-19 | Lecture | Communicating Health Advocacy and Health Promotion | Partnership; Communication Strategies for Populations | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-21 | Lecture | Professional Advocacy & Influencing | Professional organizations advocacy; Influencing change | A. Damani |
| PHARM 412 | Y3 | Fall | 2022-09-23 | Lecture | Chat Check Chart (proposed switch with Nov 2) | Minimum Standards for Patient Interaction for Patients Care | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-26 | Lecture | Professionalism in Practice | Professionalism in Practice | J. Whissell, K. Morgan |
| PHARM 412 | Y3 | Fall | 2022-09-26 | Seminar/case session | Seminar 2: Define Issue and Objectives, Generate Strategies | Write Objectives Advocacy Strategies | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-28 | Lecture | Addictions Do Not Discriminate | Stigma, Addiction | TBA |
| PHARM 412 | Y3 | Fall | 2022-10-03 | Lecture | Pharmacy & the Environment | Pharmacists Role in the Environment | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-10-03 | Lecture | Social Work and Pharmacy | Role of Social Workers | TBA |
| PHARM 412 | Y3 | Fall | 2022-10-05 | Lecture | Indigenous Health: Trauma Informed Care | Indigenous Health | G. Baehr |
| PHARM 412 | Y3 | Fall | 2022-10-07 | Lecture | Ableism - The Basics | Disabilities VAD | M. Bissell, R. Ulanicki |
| PHARM 412 | Y3 | Fall | 2022-10-12 | Lecture | Ableism - The Basics | Disabilities VAD | M. Bissell, R. Ulanicki |
| PHARM 412 | Y3 | Fall | 2022-10-14 | Lecture | Indigenous Health | Indigenous Health | A. Ruben |
| PHARM 412 | Y3 | Fall | 2022-10-17 | Lecture | Precepting Skills (Self-Study/Online Module) | Precepting Skills: Online Module | Ex Ed Team |
| PHARM 412 | Y3 | Fall | 2022-10-17 | Seminar/case session | Seminar 3: Seminar 3 Select Strategy, Create Tools and Plan | Health Advocacy Cases | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-10-19 | Lecture | Indigenous Health | Indigenous Health | J. Swidrovich |
| PHARM 412 | Y3 | Fall | 2022-10-21 | Other exam/test | Pharmacogenomic Tests in Community Pharmacy | Ethics, communication, cost-effectiveness | El Sayed |
| PHARM 412 | Y3 | Fall | 2022-10-24 | Lecture | Long Term Care | Long Term Care | C. Sadowski |
| PHARM 412 | Y3 | Fall | 2022-10-26 | Lecture | Long Term Care | Long Term Care | C. Sadowksi |
| PHARM 412 | Y3 | Fall | 2022-10-28 | Lecture | Pharmacist's Role in Public Health, Health Promotion, Disease Prevention (Pre-recorded) | Public Health, Health Promotion, Disease Prevention | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-10-31 | Lecture | A Practical Approach to Motivational Interviewing | Motivational Interviewing, Medication Experience, Reframing, Providing tailored information, Elicit-Provide-Elicit, Patient Autonomy, Sense Making, Practical Reasoning | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-10-31 | Seminar/case session | Seminar 4: Evaluate and Mitigate Risk | CSL Discussions/Project Time | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-11-02 | Lecture | Working with Vulnerable Populations | Supporting Newly Housed Individuals in the Community | S. Lawrence |
| PHARM 412 | Y3 | Fall | 2022-11-04 | Lecture | Grief in Pharmacy | Loss, Grief | T. Sutton |
| PHARM 412 | Y3 | Fall | 2022-11-07 | Lecture | Identifying human trafficking | Human Trafficking | TBA |
| PHARM 412 | Y3 | Fall | 2022-11-09 | Lecture | Self-Advocacy in Pharmacy | Corporate Pharmacy, Advocacy, Self-Care | T. Prochnau |
| PHARM 412 | Y3 | Fall | 2022-11-14 | Lecture | Precepting Skills | Precepting Skills: Applications in Practice | Ex Ed Team |
| PHARM 412 | Y3 | Fall | 2022-11-14 | Seminar/case session | Seminar 5: CSL Advocacy Showcase | CSL Advocacy Showcase | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-11-16 | Other exam/test | Diagnostic & Screening Tests | pproach to Diagnosis, Pattern recognition, Probabilistic reasoning, Test & Treatment Threshold, Understanding & Applying the Results of a Diagnostic Test Study, Sensitivity Specificity, Strep Point of Care test | Makowsky |
| PHARM 412 | Y3 | Fall | 2022-11-18 | Other exam/test | Diagnostic & Screening Tests | SpPin, SnOut, Likelihood Ratio, Multilevel Likelihood ratio, Pretest probability, Post Test probability, Fagan Nomogram, Sensitivity, Specificity, Strep Point of Care test, Lupus Lab tests - ANA, Anti dsDNA, Smith | Makowsky |
| PHARM 412 | Y3 | Fall | 2022-11-21 | Other exam/test | Diagnostic & Screening Tests | Risk of Bias in a Diagnostic Test Study. Diagnostic dilemma, Appropriate reference standard, Blinded test interpretation, Appropriate reference standard | Makowsky |
| PHARM 412 | Y3 | Fall | 2022-11-23 | Lecture | Pharmacoeconomics | Overview of PE analyses and Costs | T. Makinhova |
| PHARM 412 | Y3 | Fall | 2022-11-25 | Lecture | Pharmacoeconomics | Critique of PE study, CMA, CEA | T. Makinhova |
| PHARM 412 | Y3 | Fall | 2022-11-28 | Lecture | Pharmacoeconomics | Pharmacoeconomics | T. Makinhova |
| PHARM 412 | Y3 | Fall | 2022-11-28 | Seminar/case session | Seminar 6: Pharmacoeconomics | Pharmacoeconomic analysis | T. Makhinova |
| PHARM 412 | Y3 | Fall | 2022-11-30 | Lecture | Pharmacoeconomics | CUA, CBA | T. Makinhova |
| PHARM 412 | Y3 | Fall | 2022-12-02 | Lecture | Evaluation & Application of Clinical Practice Guidelines | Evaluation & Application of Clinical Practice Guidelines | S. Simpson |
| PHARM 412 | Y3 | Fall | 2022-12-05 | Lecture | Evaluation & Application of Clinical Practice Guidelines | Clinical practice guidelines: multimorbidity & overtreatment | S. Simpson |
| PHARM 412 | Y3 | Fall | 2022-12-07 | Lecture | Health Advocate Presentations + Wrap Up | Eval + Q&A | BASE Team |
| PHARM 413 | Y3 | Winter | 2024-01-08 | Lecture | Course and Project Overview | Behaviour: Practice change - Course and Project Overview | Makhinova |
| PHARM 413 | Y3 | Winter | 2024-01-10 | Lecture | Planning business and new service | Administration: Practice change - Business Plan | J. Shkrobot/T. Makinova |
| PHARM 413 | Y3 | Winter | 2024-01-12 | Lecture | Leadership 1: Leading Self | personal values, LEADS and leading self, strengths, cultivating personal growth | M. Anwar |
| PHARM 413 | Y3 | Winter | 2024-01-15 | Other exam/test | Leadership 2: Examples of Innovative Practice | Administration: Practice change - Practice Example | C. Oleksyn |
| PHARM 413 | Y3 | Winter | 2024-01-17 | Lecture | Group development, dynamics | Behaviour: Group formation | T. Makinova |
| PHARM 413 | Y3 | Winter | 2024-01-19 | Lecture | Leadership 3: Systems thinking | systems thinking, decision making | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-01-22 | Lecture | Evaluating Evidence for Pharmacy Services | EBM: Evidence - Evidence Evaluation | M. Makowsky |
| PHARM 413 | Y3 | Winter | 2024-01-22 | Seminar/case session | Pharmacy Environment | BASE: Project - Team Planning, Practice Setting, and Stakeholder Survey | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-01-24 | Lecture | Evaluating Evidence for Pharmacy Services | EBM: Evidence - Evidence Evaluation | M. Makowsky |
| PHARM 413 | Y3 | Winter | 2024-01-26 | Lecture | Incorporating Evidence: Application | EBM: Evidence - Incorporating evidence | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-01-26 | Laboratory | Project Open time - Instructor Available | BASE: Project | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-01-31 | Lecture | Ethics/Regulations for New Services | Administrative: Jurisprudence - Standards of Practice, Ethical Decision Making | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-02-02 | Lecture | Policy Change and Updates | Administration: Leadership - Building partnerships, forms of coalitions, people-centered care | G. Eberhart |
| PHARM 413 | Y3 | Winter | 2024-02-05 | Seminar/case session | New Service Options | BASE: Project - SWOT Analysis, Project Goal, Service Options | T. Makhinova/ J.Shkrobot/ |
| PHARM 413 | Y3 | Winter | 2024-02-05 | Lecture | New Services into Workflow | Adminstration: Practice change - Workflow Models, Workflow Analysis | J. Shkrobot/ L. Guirguis |
| PHARM 413 | Y3 | Winter | 2024-02-07 | Lecture | Team Roles & Readiness | Adminstration: Practice change - Human Rescources. Assessment of Readiness. Role Delegation | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-02-09 | Laboratory | Project Open time - Instructor Available | BASE: Project | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-02-12 | Lecture | Marketing Pharmacy Services | Adminstration: Marketing - 4Ps with Application to Pharmacy Services | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-02-14 | Lecture | Personal Selling and Talking about Services | Behaviour: Communication - Personal Selling, Patient Care as Business Model | L. Guirguis |
| PHARM 413 | Y3 | Winter | 2024-02-16 | Lecture | Financial Sustainability | Administrative: Business planning - Income statement/balance sheet changes/analysis of cash flow | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-02-26 | Lecture | Financial Sustainability #2 | Administrative: Business Planning - practical implications | M. Bearisto |
| PHARM 413 | Y3 | Winter | 2024-02-26 | Seminar/case session | New Service Delivery | BASE: Project - Workflow, learning needs and materials | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-02-28 | Lecture | Program Evaluation and Pharmacy Practice Research | EBM: Program Evaluation & Research - Program Eval vs Research | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-01 | Lecture | Program Evaluation and Quality Improvement | EBM: Program Evaluation & Research - SPO model, quality indicators | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-04 | Lecture | Program Evaluation and Research: Outcomes | EBM: Program Evaluation & Research - ECHO Model, Patient Satisfaction | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-06 | Lecture | Program Evaluation and Research: Data collection and analysis | EBM: Program Evaluation & Research - Sources of data, interviews, surveys, ethical consideration | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-08 | Laboratory | Project Open time - Instructor Available | BASE: Project | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-11 | Seminar/case session | Marketing and Sustainability | BASE: Project - Marketing Plan and Sustainability , Teamwork Review | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-03-11 | Lecture | Program Evaluation and Research: Data analysis and reporting | EBM: Program Evaluation & Research - Descriptive and inferential statistics, statistical analysis plan | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-13 | Lecture | Implementation of new service | EBM: Program Evaluation & Research - Implementation science, implementation framework | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-15 | Lecture | Leadership 4: Leadership Placement | Administration: Leadership - Placement opportunities | M. Anwar & B. Sprague |
| PHARM 413 | Y3 | Winter | 2024-03-18 | Laboratory | Project open time - Instructor Available | BASE: Project | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-20 | Lecture | Tips on Writing Executive Summary | BASE: Project | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-22 | Lecture | Application of privacy legislation to the implementation of patient care services | Adminstration: Jurisprudence - Health Information Act, Privacy Impact Assessments | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-03-25 | Lecture | Leadership 5: Women in Leadership | Administrative: Leadership - Women leadership | A. Oliver |
| PHARM 413 | Y3 | Winter | 2024-03-25 | Seminar/case session | Program Evaluation and Risk Mitigation | BASE: Project - Evaluation strategy, Risks and mitigation | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-03-27 | Laboratory | Project open time - Instructor Available | BASE: Project | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2024-04-03 | Lecture | New Pharmacy Service Presentations 1 | BASE: Project - Three Student Group Presentations | BASE team |
| PHARM 413 | Y3 | Winter | 2024-04-05 | Lecture | New Pharmacy Service Presentations 2 | New Pharmacy Service Presentations 2 | BASE Team |
| PHARM 413 | Y3 | Winter | 2024-04-05 | Lecture | New Pharmacy Service Presentations 3 | BASE: Project - Three group presentations | BASE team |
| PHARM 413 | Y3 | Winter | 2024-04-08 | Lecture | New Pharmacy Service Presentations 4 | BASE: Project - Three Student Group Presentations | BASE team |
| PHARM 413 | Y3 | Winter | 2024-04-08 | Lecture | New Pharmacy Service Presentations 5 | BASE: Project - Three Student Group Presentations | BASE team |
| PHARM 413 | Y3 | Winter | 2024-04-08 | Seminar/case session | Timelines and Ex Summary | BASE Project: Timeline, Executive Summary | T. Makhinova/ J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2024-04-10 | Lecture | New Pharmacy Service Presentations 6 | New Pharmacy Service Presentations 6 | BASE team |
| PHARM 413 | Y3 | Winter | 2024-04-12 | Lecture | Wrap-Up and Evalution | BASE: course evaluation | BASE team |
Assessment Information
| PHARM 212 | Y1 | Final | Final exam | 55% | — |
| PHARM 212 | Y1 | Midterm | Midterm exam | 29% | — |
| PHARM 212 | Y1 | Seminars 1-6 | Participation/professionalism | 0% | — |
| PHARM 212 | Y1 | eClass Quizzes (4% each) | Quiz | 16% | — |
| PHARM 213 | Y1 | EBCP Literacy Assignment | Assignment/written work | 10% | — |
| PHARM 213 | Y1 | Final Exam | Final exam | 45% | — |
| PHARM 213 | Y1 | Midterm Exam | Midterm exam | 25% | — |
| PHARM 213 | Y1 | Seminars | Other/unspecified | 0% | — |
| PHARM 213 | Y1 | Quizzes | Quiz | 20% | — |
| PHARM 312 | Y2 | Evidence Appraisal | Assignment/written work | 20% | — |
| PHARM 312 | Y2 | Final Exam | Final exam | 40% | — |
| PHARM 312 | Y2 | Midterm Exam | Midterm exam | 30% | — |
| PHARM 312 | Y2 | Seminar | Other/unspecified | 0% | — |
| PHARM 312 | Y2 | Quizzes | Quiz | 10% | — |
| PHARM 313 | Y2 | Final Exam | Final exam | 39% | — |
| PHARM 313 | Y2 | Midterm Exam | Midterm exam | 31% | — |
| PHARM 313 | Y2 | Quiz #1 | Quiz | 5% | — |
| PHARM 313 | Y2 | Quiz #2 | Quiz | 5% | — |
| PHARM 313 | Y2 | Quiz #3 | Quiz | 5% | — |
| PHARM 313 | Y2 | Quiz #4 | Quiz | 5% | — |
| PHARM 313 | Y2 | Quiz #5 | Quiz | 5% | — |
| PHARM 313 | Y2 | Quiz #6 | Quiz | 5% | — |
| PHARM 412 | Y3 | Brief Lecture Critical Reflections (BCRs) | Assignment/written work | 24% | — |
| PHARM 412 | Y3 | Health Advocacy Project | Assignment/written work | 30% | — |
| PHARM 412 | Y3 | Final | Final exam | 30% | — |
| PHARM 412 | Y3 | Seminar Attendance | Participation/professionalism | 0% | — |
| PHARM 412 | Y3 | Quizzes | Quiz | 14% | — |
| PHARM 413 | Y3 | Brief Critical Reflection (lecture) | Assignment/written work | 5% | — |
| PHARM 413 | Y3 | Implementation Plan Presentation | Assignment/written work | 20% | — |
| PHARM 413 | Y3 | Individual Leadership Reflection | Assignment/written work | 10% | — |
| PHARM 413 | Y3 | New Patient Care Service Implementation Plan | Assignment/written work | 30% | — |
| PHARM 413 | Y3 | Peer evaluation and Teamwork | Other/unspecified | 15% | — |
| PHARM 413 | Y3 | Seminar | Other/unspecified | 0% | — |
| PHARM 413 | Y3 | Quiz 1 | Quiz | 6% | — |
| PHARM 413 | Y3 | Quiz 2 | Quiz | 7% | — |
| PHARM 413 | Y3 | Quiz 3 | Quiz | 7% | — |
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 212 — PHARM 212 - BASE 1 | Y1 | Fall | 38 | 6 | 0 | Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | — |
| PHARM 213 — PHARM 213 - BASE 2 | Y1 | Winter | 37 | 6 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Other/unspecified (1); Quiz (1) | — |
| PHARM 312 — PHARM 312 - BASE 3 | Y2 | Fall | 34 | 7 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Other/unspecified (1); Quiz (1) | — |
| PHARM 313 — PHARM 313 - BASE 4 | Y2 | Winter | 38 | 6 | 0 | Final exam (1); Midterm exam (1); Quiz (5) | — |
| PHARM 412 — PHARM 412 - BASE 5 | Y3 | Fall | 35 | 6 | 0 | Assignment/written work (2); Final exam (1); Participation/professionalism (1); Quiz (1) | — |
| PHARM 413 — PHARM 413 - BASE 6 | Y3 | Winter | 33 | 6 | 5 | Assignment/written work (4); Other/unspecified (2); Quiz (3) | — |
Session Information
| PHARM 212 | Y1 | Fall | 2024-09-04 | Lecture | Intro to BASE | BASE - Intro: Structure, Theory, and Model of BASE | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-09-06 | Lecture | The Profession of Pharmacy | Administration - Role: profession, professionalism, professional identity. | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-09-09 | Lecture | Regulatory Framework | Administration - Jurisprudence: Introduction to the legislative framework that governs pharmacy practice; Legislation - federal, provincial, ACP | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-09-10 | Seminar/case session | Seminar 1: Pharmacist's Role - Teamwork Expectations | Administration - Jurisprudence: Team Rules, Expectations, and Logo, Professionalism Case Studies | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-09-11 | Lecture | Patient Assessment | Collecting appropriate information; documenting appropriate information | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-09-12 | Lecture | Medication Use Process - Dispensing - Part 1 | Describe how the medication use process intersects with the patient care process; Describe the regulatory requirements of a prescription with the medication use process; Apply the steps of the dispensing process to fill a prescription | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-09-13 | Lecture | Medication Use Process - Dispensing - Part 2 | Describe how the medication use process intersects with the patient care process; Describe the regulatory requirements of a prescription with the medication use process; Apply the steps of the dispensing process to fill a prescription | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-09-16 | Lecture | Core Communication Skills | Listening, Question Asking, Non-verbal Communication, Probes; | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-09-18 | Lecture | Medication Experience | Social - Med Exp: power/privilege, iatrogenesis, medicalization, medical gaze, medication experiences | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-09-20 | Lecture | Gathering a Focused Patient History | Behaviour - Comm Focused Hx: Building rapport, agenda setting, flexible structure, managing time | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-09-23 | Lecture | Empathy and Medication Experiences | Empathetic Responding, Building Rapport | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-09-24 | Seminar/case session | Seminar 2: Core Communication Skills | Behaviour - Comm: listening, empathy | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-09-25 | Lecture | Medication Monitoring (aka Refills) | Questions asking, non-adherence, direct and non-threatening strategies | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-09-27 | Lecture | Professional Communication with Emotional Patients | Behaviour - Comm Emotional: Communicating with Emotional Patients | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-10-02 | Lecture | Documenting Prescription Order Activities - Part 1 | Apply communication techniques (NOD and SBAR) when clarifying and / or requesting information pertaining to a prescription | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-10-04 | Lecture | Documenting Prescription Order Activities - Part 2 | Differentiate the requirements of written, verbal, faxed and e-prescriptions; Demonstrate how to transfer and how to receive a transfer of a prescription | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-10-07 | Lecture | Practice Expectations | Identify practice expectations of pharmacists defined through the practice framework; Describe the role of pharmacists and restricted activities we perform | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-10-08 | Seminar/case session | Seminar 3: Drug Information Resources | Evidence - EBM: -Evaluating the credibility of online health/drug/pharmacy resources; Finding/Using Summary Resources | J. Kung |
| PHARM 212 | Y1 | Fall | 2024-10-09 | Lecture | Introduction to the BASE Evidence Stream | Evidence - EBM: Overview of BASE Evidence Curriculum, (Evidence Based Clinical Practice, Drug Information, & Health Informatics | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2024-10-11 | Lecture | Introduction to Evidence Based Clinical Practice | Evidence - EBM: Intro to Evidence Based Clinical Practice | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2024-10-16 | Lecture | Introduction to Drug Information | Evidence - EBM: Defining Information Resources | K. Sorensen |
| PHARM 212 | Y1 | Fall | 2024-10-18 | Lecture | Drug Information Resources | Evidence - EBM: Systematic Approach to Answering (Drug Information) Questions | K. Sorensen |
| PHARM 212 | Y1 | Fall | 2024-10-21 | Lecture | Systematic Approach to Drug Information | Evidence - EBM: Introduction to Summary Resources: Systematic Reviews/Meta-Analysis | K. Sorenson |
| PHARM 212 | Y1 | Fall | 2024-10-23 | Midterm exam | Midterm | MIDTERM | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-10-25 | Lecture | Information Mastery, Using Information Resources at the Point of Care | Evidence - EBM: Systematic Approach to Answering (Drug Information) Questions | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2024-10-28 | Lecture | Accessing High Quality Evidence in Practice: Overview of the 6S Approach | Evidence - EBM: Information Management: Using Information Resources at the Point of Care | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2024-10-29 | Seminar/case session | Seminar 4: Equity, Diversity, Inclusivity - Practice expectations | Review of EDI principles with a focus on racism within the pharmacy space | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-10-30 | Lecture | Clinical Practice Guidelines 101 | Evidence - EBM: Information Management: Overview of the 6S approach | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2024-11-01 | Lecture | Systematic Reviews 101 | Evidence - EBM: Introduction to Summary Resources: Clinical Practice Guidelines | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2024-11-04 | Lecture | Professional Discipline Process (ACP) | Administration - Ethics: Discipline process, Mitigating errors | J. Krempien |
| PHARM 212 | Y1 | Fall | 2024-11-06 | Lecture | Ethics and the pharmacy profession | Administration - Ethics: Introduction to the ACP Code of Ethics beneficence, nonmaleficence, autonomy, and informed consent | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-11-12 | Seminar/case session | Seminar 5: Ethical principles in practice | Argue both sides of an ethical issue using ethical principles from the Alberta College of Pharmacy's Code of Ethics | J. Shkrobot, J. Krempien, J. Whissell |
| PHARM 212 | Y1 | Fall | 2024-11-13 | Lecture | Prescription drug pricing and Insurance model for prescription drug benefits | Calculate the cost of prescription medications in a community pharmacy practice setting in Alberta; Determine how insurance for prescription drug benefits impacts patients’ medication costs | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-11-15 | Lecture | Alberta Government Sponsored Drug Benefit Plans | Differentiate the government sponsored Alberta Blue Cross drug plans; Describe the Alberta Drug Benefit List and Alberta Drug Benefit Supplement; Apply principles of the iDBL to prescription pricing; Describe the Special Authorization process administered by Alberta Blue Cross | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-11-18 | Lecture | Other Drug Benefit Plans | Federal and Privately Administered Drug Plans | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-11-20 | Lecture | Debrief of Community Pharmacy Visit | Professional identity formation | J. Shkrobot, J. Hall |
| PHARM 212 | Y1 | Fall | 2024-11-22 | Lecture | How can sociology help pharmacists? | Social - Soc -Intro: Psychosocial perspectives on medication use | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-11-25 | Lecture | Medication Taking Theory | Social - Med Taking: Theory of Adherence vs. Compliance, Intelligent Noncompliance, Necessity-Concerns Framework | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2024-11-26 | Seminar/case session | Seminar 6: Effective Team Management | Application of team skills in practice based scenarios | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-11-27 | Lecture | Social Determinants of Health (SDoH) | Social - SDoH: social determinants of health, health equity, health disparities, health equities, social gradient, health in all policies | TBD |
| PHARM 212 | Y1 | Fall | 2024-11-29 | Lecture | Social Determinants of Health (SDoH) | Social - SDoH: 14 Social determinants of health, Poverty: A clinical tool for primary care providers | TBD |
| PHARM 212 | Y1 | Fall | 2024-12-02 | Lecture | Indigenous Health and Pharmacy | Social - Indigenous: Indigenous terminology, myths, Indian Status in Canada, We-are-Treaty People | A. Ruben |
| PHARM 212 | Y1 | Fall | 2024-12-04 | Lecture | Indigenous Health and Pharmacy | Social - Indigenous: Indigenous Health Issues: clean water, safe housing, and support families, Discrimination in health care, Brain Sinclar story | A. Ruben |
| PHARM 212 | Y1 | Fall | 2024-12-06 | Lecture | Non-Insured Health Benefits (NIHB) | Describe Non-Insured Health Benefits (NIHB) program; Assess eligibility for NIHB benefits; Navigate the NIHB Drug Benefit List; Apply principles of NIHB coverage to patient cases | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2024-12-09 | Lecture | Wrap-Up Lecture | BASE - Wrap-Up, Course Evaluation | BASE Team |
| PHARM 213 | Y1 | Winter | 2025-01-06 | Lecture | Health Literacy I | Behaviour - Health literacy criteria, identification, strategies | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-08 | Lecture | Health Literacy II | Behaviour - Health literacy | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-10 | Lecture | Individual Patient Education | Behaviour - Educational strategies - verbal and written; tailoring, readability, chunking, teach-back | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-13 | Lecture | Written Materials | Behaviour - Plain language and readability | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-14 | Seminar/case session | Educational Materials Seminar | Behaviour - Teach-back | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-15 | Lecture | Communicating Risk About Medications | Behaviour - Visual/oral communication; palling palettes, odds, direction | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-17 | Lecture | Patient-Centred Interviewing | Patient centred communication, identifying goals, transitions and signposts | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-20 | Lecture | Introduction to Jurisprudence & Federal Jurisprudence I | Administration - Food and Drugs Act/Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-22 | Lecture | Federal Jurisprudence II | Administration - Food and Drugs Act/Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-24 | Lecture | Federal Jurisprudence III | Administration - Controlled Drugs and Substances Act/Regulations/Schedules | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-27 | Lecture | Federal Jurisprudence IV | Administration - Part G & J of the Food and Drugs Act/Tracked Prescription Program | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-28 | Seminar/case session | Tracked Prescription Program Seminar | Administration - Narcotic Regulation Practice Cases, Administration - Tracked Prescription Program | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-29 | Lecture | Drug Diversion and Robbery Prevention | Administration - Drug Diversion and Robbery Prevention Techniques | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-31 | Lecture | Substance Abuse by Pharmacists | Administration - Abuse of Substances by Pharmacists | J. Krempien |
| PHARM 213 | Y1 | Winter | 2025-02-03 | Lecture | Provincial Jurisprudence I | Administration - Health Professions Act/Pharmacy and Drug Act | B. Willsey, D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-05 | Lecture | Provincial Jurisprudence II | Administration - Health Information Act | B. Willsey, D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-06 | Lecture | Provincial Jurisprudence III | Administration - ACP Guidance | B. Willsey/D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-07 | Lecture | Drug Scheduling | Administration - Drug Scheduling | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-10 | Lecture | Jurisprudence Application | Administration - Drug Scheduling Application, Administration - Legislation Application | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-12 | Lecture | Additional Jurisprudence Topics | Administration - Other HCP Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-14 | Lecture | ACP Standards of Practice | Administration - ACP Standards of Practice, Administration - Pharmacist Prescribing | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-24 | Lecture | Fostering a Culture of Patient Safety | Administration - Patient Safety | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-25 | Seminar/case session | Jurisprudence Seminar | Administration - Jurisprudence Cases | J. Krempien, J. Whissell |
| PHARM 213 | Y1 | Winter | 2025-02-26 | Lecture | Disclosure of Medical Errors | Behaviour - Strategies for disclosing errors | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-02-28 | Lecture | Evidence Literacy | Evidence - Reading a trial, synopsis | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-04 | Seminar/case session | Finding Studies & Synopses | Evidence - Evidence Literacy Seminar | J. Kung/M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-05 | Lecture | Trial Designs | Evidence - Overview of experimental and observational designs & introduction to RCTs | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-07 | Lecture | Evidence and Drug Development | Evidence - Drug policy and review process | S. Alsaadi |
| PHARM 213 | Y1 | Winter | 2025-03-10 | Lecture | Study Results I | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-12 | Lecture | Study Results II | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-14 | Lecture | Study Results III | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-17 | Lecture | Confidence Intervals | Evidence - Confidence Intervals | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-18 | Seminar/case session | Journal Club Seminar | Evidence - Topics listed on eClass | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-19 | Lecture | Measuring Patient Experiences | Evidence - Continuous data (Scales); Comparison of 2 Means; Comparison of 2 Proportions; Power and Sample Size | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-21 | Lecture | Meta Analysis Results | Evidence - Forest plot, pooled OR, SMD, WMD | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-24 | Lecture | Time to Event Outcomes, Survival Analysis, & Hazard Ratios | Evidence - Hazard Ratios, time to event, and survival analysis | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-26 | Lecture | BASE Flex Lecture | Addressing Student Learning Needs | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-03-28 | Lecture | Talking About Change: Smoking Cessation | Behaviour - Transtheoretical Model | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-03-31 | Lecture | Leading Self | Behaviour - Leading Self | T. Makhinova |
| PHARM 213 | Y1 | Winter | 2025-04-01 | Seminar/case session | Leading Self Seminar | Behaviour - Leading Self | T. Makhinova |
| PHARM 213 | Y1 | Winter | 2025-04-02 | Lecture | Professional Learning | Behaviour - Professional Learning | P. Timanson |
| PHARM 213 | Y1 | Winter | 2025-04-04 | Lecture | Continuing Professional Development | Behaviour - CPD Process, ACP Continuing Competence Program | P. Timanson |
| PHARM 213 | Y1 | Winter | 2025-04-07 | Lecture | Communicating with Children | Behaviour - Communicating with children | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-04-09 | Final exam | BASE Wrap-Up, SPoT Survey, & Final Exam Review | BASE - Review, wrap up | All Lecturers |
| PHARM 312 | Y2 | Fall | 2023-09-06 | Lecture | Course Introduction & Healthcare Resources | Canada Health Act, Accreditation Canada, College of Physicians & Surgeons of Alberta, Patient & Public Involvement in Healthcare, Cost of Healthcare resources | J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2023-09-06 | Lecture | Lecture 1- Course Introduction | Course Intro | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-09-08 | Lecture | Provision of Healthcare Services | Public Health (PHAC). Emergency Care. Primary/Ambulatory Care. Inpatient/Specialized Care. Homecare. Long-term care. Rehabilitation.Palliative Care. Mental Health. Dental Care. Complementary & Alternative Medicine. First Nations and Inuit Health Services | J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2023-09-11 | Lecture | Health system organizations | Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), Canadian Institute for Health Information (CIHI), Alberta Health (AH), Alberta Health Services (AHS), Health Quality Council of Alberta (HQCA), Canadian Pharmacists Association (CPhA), Neighborhood Pharmacy Association of Canada, Canadian Society of Hospital Pharmacists (CSHP), Alberta College of Pharmacy (ACP), Alberta Pharmacists' Association (RxA) | J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2023-09-13 | Lecture | Medication Use Process in the Hospital Setting | Mission & Vision of AHS Pharmacy Services, Medication Distribution Systems, Automated Dispensing cabinets, Unit Dose, Bulk Tablet Repackaging, Centralized IV Additive Service, Direct Patient Care Service, Medication Safety | K. Olstad |
| PHARM 312 | Y2 | Fall | 2023-09-15 | Lecture | Medication Use Process in the Hospital Setting | Connect Care/EPIC, Medication Reconciliation, Antimicrobial Stewardship, Drugs and Therapeutics Committee, Backorder & Shortage management, Parenteral monographs, Barcoding, Closed Loop medication management | K. Olstad |
| PHARM 312 | Y2 | Fall | 2023-09-18 | Lecture | Leadership: Constructive negotiations | Positional Negotiation, Best Alternative to a Negotiated Agreement, Reservation value, Aspiration value, Zone of possible agreement, Principled negotiation, Failed negotiations | T. Makhinova |
| PHARM 312 | Y2 | Fall | 2023-09-20 | Lecture | How to RELATE and RESPOND to patients in the hospital. | Tips to Interact with Patients & Families in Hospital | L. Guirguis |
| PHARM 312 | Y2 | Fall | 2023-09-21 | Seminar/case session | Constructive Negotiation- Seminar | Positional Negotiation, Principled Negotiation | T. Makhinova |
| PHARM 312 | Y2 | Fall | 2023-09-25 | Lecture | Introduction to the Legal System/The Alberta Court System | Law, Legal system, Institutions of law, Sources of law, Types of legal actions, Canadian Court System, Alberta Court System | M. Yu |
| PHARM 312 | Y2 | Fall | 2023-09-27 | Lecture | Legal Obligations of Regulated Health Care Professionals | Courts vs. Regulators, Regulatory Tools, Professional Liability Insurance, Continuing competence, Breach of Standards of Practice, Drug Diversion, Record Keeping, Character & Reputation | C. Field |
| PHARM 312 | Y2 | Fall | 2023-09-29 | Lecture | Privacy Law (Part 1) | FOIPPA, PIPEDA, CASL, PIPA, HIA, Personal Information, Collection, Use, Disclosure | M. Yu |
| PHARM 312 | Y2 | Fall | 2023-10-02 | Lecture | Privacy Law (Part 2) | Health Information Act- Use, Disclosure, Breach, Compliance | M. Yu |
| PHARM 312 | Y2 | Fall | 2023-10-04 | Lecture | Law of Negligence: Duty & Standard of Care | Torts, Negligence, Duty of care, Standard of care | J. Jackson |
| PHARM 312 | Y2 | Fall | 2023-10-05 | Seminar/case session | Contemporary Issues in Pharmacy Informatics - Seminar | Contemporary Issues in Pharmacy Informatics | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-10-06 | Lecture | Law of Negligence: Causation & Damages | Factual & Legal Causation, Reasonable Foreseeability | J. Jackson |
| PHARM 312 | Y2 | Fall | 2023-10-11 | Lecture | Law of Negligence: Causation & Damages | Damages and forms of compensation, Pecuniary Damages, Non-pecuniary | J. Jackson |
| PHARM 312 | Y2 | Fall | 2023-10-13 | Lecture | Law of Negligence: Defences | Contributory negligence, Voluntary assumption of risk, Illegality, Expiration of time limit for instituting a legal action | J. Jackson |
| PHARM 312 | Y2 | Fall | 2023-10-16 | Lecture | Medical Assistance in Dying: Legal Framework & Role of the Pharmacist | Federal Legislation for MAID, Truchon vs. Procureur, AHS MAID Policy, Track 1 vs. Track 2 | C. Field |
| PHARM 312 | Y2 | Fall | 2023-10-18 | Lecture | Consent and Informed Consent | Voluntary Consent, Capacity (Adults, minors), Elements of Informed Consent | C. Field |
| PHARM 312 | Y2 | Fall | 2023-10-19 | Seminar/case session | Law- Seminar | Negligence, Privacy Law | M. Yu |
| PHARM 312 | Y2 | Fall | 2023-10-20 | Other exam/test | Pharmacogenomic Testing: Ethical and legal considerations | Personalized & Precision Medicine, Fundamentals of Genetics (Genotype, Phenotype), Informed Consent for PGx testing, Privacy, Genetic information Nondiscrimination Act | D. El Sayed |
| PHARM 312 | Y2 | Fall | 2023-10-23 | Lecture | Introduction to Critical Appraisal of a RCT | Assessing Cause & Effect, JAMA Approach to Critical Appraisal of a Therapy Study, Strategies to reduce Bias, Steps to practice EBM, Using Pre-Appraised Resources, Bias & Random Error | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-10-27 | Lecture | Critical Appraisal of a RCT- Assessing Risk of Bias II | Randomization, Allocation concealment, Balancing prognostic factors | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-01 | Seminar/case session | Critical Appraisal of a RCT - Risk of Bias III | Blinding, Loss to followup | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-02 | Seminar/case session | Evidence Appraisal - RCT/NIFT- Seminar | Creating a Study Synopsis, Evidence Appraisal & Application to Patient care | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-03 | Lecture | Critical Appraisal of a RCT - Risk of Bias IV | Intention to Treat Analysis, Per Protocol Analysis, On Treatment analysis, Stopping Rules, Funding Bias | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-06 | Lecture | Critical Appraisal of a RCT - Study Results & Application to patient care | Magnitude & Precision of Effect, Internal & External validity, Subgroup analysis, Drug Class effects, Surrogate vs. Patient Important Outcomes, Composite Endpoints, Personalizing Risks & Benefit Information for Individual Patients. | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-08 | Lecture | Evaluation & Application of Systematic Reviews - Part 1: Search and Selection | Systematic Review, Meta analysis, Review Registration, PRISMA, Characteristics of a Credible review, Heterogeneity | S. Simpson |
| PHARM 312 | Y2 | Fall | 2023-11-10 | Lecture | Evaluation & Application of Systematic Reviews – Part 2: Data Abstraction and Analysis | Risk of BIas Assessment, Publication Bias, Sensitivity Analysis, Assessment of Heterogeneity, Fixed & Random Effects Models, Network Meta analysis | S. Simpson |
| PHARM 312 | Y2 | Fall | 2023-11-15 | Lecture | Finding the Best Evidence | Searching at the Point of Care, Systematic Literature Searching, PubMed | J. Kung |
| PHARM 312 | Y2 | Fall | 2023-11-16 | Seminar/case session | Evidence Appraisal - Systematic Reviews - Seminar | Creating a Synopsis, Evidence Appraisal & Application to Patient care | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-17 | Lecture | Critical Appraisal of a Non-Inferiority Trial | Superiority vs. Equivalence, vs. Non-inferiority, JAMA Approach to evaluating Non Inferiority Studies | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-17 | Lecture | Critical Appraisal of a study that measures patient experience | Instruments to measure health status, Attributes of high quality trials assessing health status, Face Validity, Content validity, Construct validity, Reliability, Responsiveness, Precision, Reproducibility, Internal consistency, Interpretability, Minimal Clinically Important Difference | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-21 | Lecture | Critical Appraisal of a Non-Inferiority Trial – Methodological Issues ITT & PPA | Appropriate active control, Appropriate patients & outcomes, Optimal application of treatment regimens, Intention to treat vs. Per Protocol Analysis, Establishing the non inferiority margin, Sample size | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2023-11-24 | Lecture | Indigenous Peoples & Access to Pharmacist Care | Health Equity, FNIHB, NIHB Benefit Program | A. Ruben |
| PHARM 312 | Y2 | Fall | 2023-11-27 | Lecture | Indigenous Peoples & Access to Pharmacist Care | Provision of Pharmacy Services to Indigenous Populations | A. Ruben |
| PHARM 312 | Y2 | Fall | 2023-11-29 | Lecture | Hospital Pharmacists' Role as Educator | Skills & Knowledge required to educate groups of patients, Pharmacist experiences in providing group education, Benefits of group education for patients. | T. Schindel |
| PHARM 312 | Y2 | Fall | 2023-11-30 | Seminar/case session | Developing Education Plans for Groups of Patients - Seminar | Creating an Education Plan | T. Schindel |
| PHARM 312 | Y2 | Fall | 2023-12-01 | Lecture | Basics of Learning Theories: Supporting your Role as Educator | Learning Theory; Theoretic frameworks (Behaviorism, humanism, cognitivism, social cognitive, constructivism, critical) | T. Schindel |
| PHARM 312 | Y2 | Fall | 2023-12-04 | Lecture | Designing and Evaluating Education | ADDIE Framework; SMART objectives, Blooms Taxonomy; Formative & Summative Assessment, Program Evaluation | T. Schindel |
| PHARM 312 | Y2 | Fall | 2023-12-08 | Lecture | Wrap Up Lecture: Course Evaluation and Q&A | USRI Course Evaluation, Final Exam Overview, Question & Answer | M. Makowsky |
| PHARM 313 | Y2 | Winter | 2025-01-06 | Lecture | Introduction, Practice shared decision making / risk communication | Behaviour - Shared decision making: Evaluate tools to communicate risk to patients | J. Shkrobot / L. Guirguis |
| PHARM 313 | Y2 | Winter | 2025-01-08 | Lecture | Practice shared decision making / risk communication | Behaviour - Shared decision making: Principles of shared decision making, Comparing shared decision making to traditional communication approaches | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2025-01-09 | Seminar/case session | Shared decision making | Behaviour - Shared decision making: Applying shared decision making principles in patient scenarios | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2025-01-10 | Lecture | Complex Communication - Working with people who have a disability or do not share a common language | Pictograms, Working with a translator; Disability | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2025-01-13 | Lecture | Complex Communication - Facilitating Behaviour Change | Motivational Interviewing | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2025-01-15 | Lecture | Introduction to Pharmacoepidemiology and Limitations of Premarket Evidence | Evidence - Intro to pharmacoepidemiology: Define pharmacoepidemiology terms, Link pharmacoepidemiology and patient care processes | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-01-17 | Lecture | Randomized Controlled Trials and Observational Studies - Why do we need both? | Evidence - Drug approvals: Drug approval process, Pre-marketing clinical trials, resources for decision making, Resources for decision making | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-01-20 | Lecture | Adverse Drug Reaction Reporting and Drug Safety | Evidence - ADR databases: Drug / outcome associations, Spontaneous adverse drug reaction reports and databases, Safety signals | K. Popovic |
| PHARM 313 | Y2 | Winter | 2025-01-22 | Lecture | Common Data Sources Used to Assess Drug Safety and Effectiveness | Evidence - Secondary analysis: Secondary analysis, Prospective cohorts and population based surveys, Data resources for pharmacoepidemiology studies | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-01-23 | Seminar/case session | EBM Seminar 1 - Searching for Drug Safety and Effectiveness Studies | Evidence - Observational research: Finding pharmacoepidemiologic studies to answer patient care questions | J. Kung |
| PHARM 313 | Y2 | Winter | 2025-01-24 | Lecture | Pharmacoepidemiologic Study Designs Part 1: Cross Sectional and Case-Control Studies | Evidence - Pharmacoepidemiology study designs: Cross sectional and case controlled studies, Advantages and limitations of study designs | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-01-27 | Lecture | Pharmacoepidemiologic Study Designs Part 2: Cohort Studies | Evidence - Pharmacoepidemiology study designs: Cohort and nested case control studies, Advantages and limitations of study designs | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-01-29 | Lecture | Defining Variables and Building a Case for Causality | Variable definitions, Causal Interference, Common considerations used in pharmacoepidemiology | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-01-31 | Lecture | Bias in Pharmacoepidemiologic Studies | Evidence - Bias: Strengths and weaknesses of the major observational study designs | S. Hameed |
| PHARM 313 | Y2 | Winter | 2025-02-03 | Lecture | Confounding in Pharmacoepidemiologic Studies | Evidence - Confounding: Confounding and how to minimize its effects in pharmacoepidemiologic studies | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-02-05 | Lecture | Statistical Analyses in Pharmacoepidemiologic Studies | Common measures of association, Relative, Absolute, Hazard ratio, Common terms in statisical analysis of observational studies, Effect modification and interaction | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-02-06 | Seminar/case session | EBM Seminar 2 - Critical Appraisal of a Pharmacoepidemiologic Study | Evidence - EBM application: Find, evaluate and apply data from pharmacoepidemiologic research to answer patient care questions | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-02-07 | Lecture | Other Applications of Pharmacoepidemiologic Studies | Evidence - Drug utilization: Types of drug utilization studies, their use and intervention strategies | S. Simpson |
| PHARM 313 | Y2 | Winter | 2025-02-10 | Lecture | Strategic Planning | Administration - Strategic planning: Strategic planning, SWOT analysis, Competitive strategies, SMART objectives | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-02-12 | Lecture | Change Management | Administration - Change management: Risk of change vs not changing, Kotter's 8-step model of change | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-02-14 | Lecture | Planning and implementing patient care services | Administration - Planning patient services: Pharmacy based patient care services, Best practices related to the patient experience, Barriers to new service implementation, Performance measures for patient care services | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-02-24 | Lecture | Grief in Pharmacy | Types of loss, Grief reactions, Dealing with grief | M. Agopsowicz |
| PHARM 313 | Y2 | Winter | 2025-02-26 | Midterm exam | Midterm Exam | Midterm exam | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-02-27 | Seminar/case session | Case Studies - Change Management | Administration - Change management: Apply change management strategies to scenarios that may occur within a health team | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-02-28 | Lecture | Role of Pharmacy Licensee - Part 1 | Administration - Pharmacy Licensee: Regulatory responsibilities of a pharmacy licensee, Comparison of licensee and pharmacist responsibilities | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-03 | Lecture | Role of Pharmacy Licensee - Part 2 | Pharmacy Licensee: Regulatory responsibilities of a pharmacy licensee, Comparison of licensee and pharmacist responsibilities | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-05 | Lecture | Human resource management - Part 1 | Administration - Human resources: Employment legislation, Termination of employment, Union vs non-union employment environments | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-07 | Lecture | Human resource management - Part 2 | Administration - Human resources: Sourcing candidates for employment , Evaluation process for hiring, Negotiation, Orientation / training | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-10 | Lecture | Human resource management - Part 3 | Administration - Human resources: Best practices for HR management, Job descriptions | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-12 | Lecture | Inventory Management | Administration - Inventory management: Principles of inventory management, Sources of supply, Inventory management tools / processes | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-12 | Lecture | Pharmacy Compensation Framework - Part 1 | Alberta's compensation plan for pharmacy services (adaptations, injections, CACP, SMMA), Compensation for services not related to the dispensing of medication | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-13 | Seminar/case session | Case studies - Human resources management | Solve human resource management issues / case studies | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-14 | Lecture | Pharmacy Compensation Framework - Part 2 | Alberta's compensation plan for pharmacy services (adaptations, injections, CACP, SMMA), Compensation for services not related to the dispensing of medication | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-17 | Lecture | Errors in community and hospital settings - Part 1 | Administration - Medication errors: Analyze examples of medication errors | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-19 | Lecture | Errors in community and hospital settings - Part 2 | Administration - Medication errors: Explore mechanisms by which errors can be reduced | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-21 | Lecture | Root Cause Analysis | Administration - Root cause analysis: Define the root cause analysis methodology, Apply root cause analysis to practice scenarios | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-24 | Lecture | Failure Mode and Effects Analysis | Administration - FMEA: Define FMEA, Apply FMEA in a practice scenario | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-26 | Lecture | Risk Management | Administration - Risk management: Types of risk, Risk management plan, Risk management strategies | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-27 | Seminar/case session | Peer Assisted Learning | Define the peer learning model and why it works; Discuss the attributes of a good peer to optimize a PAL placement; Practice skills that enable you to be a good peer; Identify activities that can be done with a peer on placement. | A. Thompson, M. MacDonald, S. Khurana |
| PHARM 313 | Y2 | Winter | 2025-03-28 | Lecture | Finance - Part 1 | Administration - Finances: Income statement, Balance sheet, Interpretation of financial statements, Gross margin, Gross profit | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-03-31 | Lecture | Finance - Part 2 | Administration - Finances: Cash flow statement, Key financial ratios | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-04-02 | Lecture | Marketing | Administration - Marketing: Marketing concepts, 4 P's, Consumer behaviour, Market segmentation | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2025-04-04 | Lecture | Older Adults, Ageism, and Age Friendly Practice | Social - Pharmacy organizations: Age Friendly Pharmacy, Patient perspectives on pharmacy | C. Sadowski |
| PHARM 313 | Y2 | Winter | 2025-04-07 | Lecture | Evaluating Communication in Pharmacy Organizations | Social - Pharmacy organizations: Health literacy assessment, Organizational health literacy, Measurement, Medication coordination | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2025-04-09 | Lecture | Wrap Up Lecture | BASE - Review: Wrap Up | BASE Team |
| PHARM 412 | Y3 | Fall | 2022-09-02 | Lecture | Orientation to BASE 5; Health Advocacy in Pharmacy | Social Determinants of Health, Advocacy | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-07 | Lecture | Social Location & Pharmacy | Social Location, Privilege, SDoH | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-09 | Lecture | Critical Reflection in Health Advocacy | Critical Reflection | L. Guiguis |
| PHARM 412 | Y3 | Fall | 2022-09-12 | Lecture | Pharmacist Advocate | Pharmacist Advocate | L.Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-12 | Seminar/case session | Seminar 1: Pharmacist Roles and Community Partner | Advocacy and Community Service Learning; Baseline teamwork | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-14 | Lecture | Patient Advocacy | Patient Advocacy -Patient, Organization, and Society | B.Kidd |
| PHARM 412 | Y3 | Fall | 2022-09-16 | Lecture | Advocacy Approaches | Forms of Advocacy | L.Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-19 | Lecture | Communicating Health Advocacy and Health Promotion | Partnership; Communication Strategies for Populations | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-21 | Lecture | Professional Advocacy & Influencing | Professional organizations advocacy; Influencing change | A. Damani |
| PHARM 412 | Y3 | Fall | 2022-09-23 | Lecture | Chat Check Chart (proposed switch with Nov 2) | Minimum Standards for Patient Interaction for Patients Care | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-26 | Lecture | Professionalism in Practice | Professionalism in Practice | J. Whissell, K. Morgan |
| PHARM 412 | Y3 | Fall | 2022-09-26 | Seminar/case session | Seminar 2: Define Issue and Objectives, Generate Strategies | Write Objectives Advocacy Strategies | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-09-28 | Lecture | Addictions Do Not Discriminate | Stigma, Addiction | TBA |
| PHARM 412 | Y3 | Fall | 2022-10-03 | Lecture | Pharmacy & the Environment | Pharmacists Role in the Environment | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-10-03 | Lecture | Social Work and Pharmacy | Role of Social Workers | TBA |
| PHARM 412 | Y3 | Fall | 2022-10-05 | Lecture | Indigenous Health: Trauma Informed Care | Indigenous Health | G. Baehr |
| PHARM 412 | Y3 | Fall | 2022-10-07 | Lecture | Ableism - The Basics | Disabilities VAD | M. Bissell, R. Ulanicki |
| PHARM 412 | Y3 | Fall | 2022-10-12 | Lecture | Ableism - The Basics | Disabilities VAD | M. Bissell, R. Ulanicki |
| PHARM 412 | Y3 | Fall | 2022-10-14 | Lecture | Indigenous Health | Indigenous Health | A. Ruben |
| PHARM 412 | Y3 | Fall | 2022-10-17 | Lecture | Precepting Skills (Self-Study/Online Module) | Precepting Skills: Online Module | Ex Ed Team |
| PHARM 412 | Y3 | Fall | 2022-10-17 | Seminar/case session | Seminar 3: Seminar 3 Select Strategy, Create Tools and Plan | Health Advocacy Cases | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-10-19 | Lecture | Indigenous Health | Indigenous Health | J. Swidrovich |
| PHARM 412 | Y3 | Fall | 2022-10-21 | Other exam/test | Pharmacogenomic Tests in Community Pharmacy | Ethics, communication, cost-effectiveness | El Sayed |
| PHARM 412 | Y3 | Fall | 2022-10-24 | Lecture | Long Term Care | Long Term Care | C. Sadowski |
| PHARM 412 | Y3 | Fall | 2022-10-26 | Lecture | Long Term Care | Long Term Care | C. Sadowksi |
| PHARM 412 | Y3 | Fall | 2022-10-28 | Lecture | Pharmacist's Role in Public Health, Health Promotion, Disease Prevention (Pre-recorded) | Public Health, Health Promotion, Disease Prevention | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-10-31 | Lecture | A Practical Approach to Motivational Interviewing | Motivational Interviewing, Medication Experience, Reframing, Providing tailored information, Elicit-Provide-Elicit, Patient Autonomy, Sense Making, Practical Reasoning | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-10-31 | Seminar/case session | Seminar 4: Evaluate and Mitigate Risk | CSL Discussions/Project Time | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-11-02 | Lecture | Working with Vulnerable Populations | Supporting Newly Housed Individuals in the Community | S. Lawrence |
| PHARM 412 | Y3 | Fall | 2022-11-04 | Lecture | Grief in Pharmacy | Loss, Grief | T. Sutton |
| PHARM 412 | Y3 | Fall | 2022-11-07 | Lecture | Identifying human trafficking | Human Trafficking | TBA |
| PHARM 412 | Y3 | Fall | 2022-11-09 | Lecture | Self-Advocacy in Pharmacy | Corporate Pharmacy, Advocacy, Self-Care | T. Prochnau |
| PHARM 412 | Y3 | Fall | 2022-11-14 | Lecture | Precepting Skills | Precepting Skills: Applications in Practice | Ex Ed Team |
| PHARM 412 | Y3 | Fall | 2022-11-14 | Seminar/case session | Seminar 5: CSL Advocacy Showcase | CSL Advocacy Showcase | L. Guirguis |
| PHARM 412 | Y3 | Fall | 2022-11-16 | Other exam/test | Diagnostic & Screening Tests | pproach to Diagnosis, Pattern recognition, Probabilistic reasoning, Test & Treatment Threshold, Understanding & Applying the Results of a Diagnostic Test Study, Sensitivity Specificity, Strep Point of Care test | Makowsky |
| PHARM 412 | Y3 | Fall | 2022-11-18 | Other exam/test | Diagnostic & Screening Tests | SpPin, SnOut, Likelihood Ratio, Multilevel Likelihood ratio, Pretest probability, Post Test probability, Fagan Nomogram, Sensitivity, Specificity, Strep Point of Care test, Lupus Lab tests - ANA, Anti dsDNA, Smith | Makowsky |
| PHARM 412 | Y3 | Fall | 2022-11-21 | Other exam/test | Diagnostic & Screening Tests | Risk of Bias in a Diagnostic Test Study. Diagnostic dilemma, Appropriate reference standard, Blinded test interpretation, Appropriate reference standard | Makowsky |
| PHARM 412 | Y3 | Fall | 2022-11-23 | Lecture | Pharmacoeconomics | Overview of PE analyses and Costs | T. Makinhova |
| PHARM 412 | Y3 | Fall | 2022-11-25 | Lecture | Pharmacoeconomics | Critique of PE study, CMA, CEA | T. Makinhova |
| PHARM 412 | Y3 | Fall | 2022-11-28 | Lecture | Pharmacoeconomics | Pharmacoeconomics | T. Makinhova |
| PHARM 412 | Y3 | Fall | 2022-11-28 | Seminar/case session | Seminar 6: Pharmacoeconomics | Pharmacoeconomic analysis | T. Makhinova |
| PHARM 412 | Y3 | Fall | 2022-11-30 | Lecture | Pharmacoeconomics | CUA, CBA | T. Makinhova |
| PHARM 412 | Y3 | Fall | 2022-12-02 | Lecture | Evaluation & Application of Clinical Practice Guidelines | Evaluation & Application of Clinical Practice Guidelines | S. Simpson |
| PHARM 412 | Y3 | Fall | 2022-12-05 | Lecture | Evaluation & Application of Clinical Practice Guidelines | Clinical practice guidelines: multimorbidity & overtreatment | S. Simpson |
| PHARM 412 | Y3 | Fall | 2022-12-07 | Lecture | Health Advocate Presentations + Wrap Up | Eval + Q&A | BASE Team |
| PHARM 413 | Y3 | Winter | 2025-01-06 | Lecture | Course and Project Overview | Behaviour: Practice change - Course and Project Overview | Makhinova |
| PHARM 413 | Y3 | Winter | 2025-01-08 | Lecture | Planning business and new service | Administration: Practice change - Business Plan | J. Shkrobot/T. Makinova |
| PHARM 413 | Y3 | Winter | 2025-01-10 | Other exam/test | Leadership 1: Examples of Innovative Practice | Administration: Practice change - Practice Example | C. Oleksyn |
| PHARM 413 | Y3 | Winter | 2025-01-13 | Lecture | Leadership 2: Leading Self | personal values, LEADS and leading self, strengths, cultivating personal growth | M. Anwar |
| PHARM 413 | Y3 | Winter | 2025-01-15 | Lecture | Leadership 3: Systems thinking | systems thinking, decision making | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-01-17 | Lecture | Evaluating Evidence for Pharmacy Services | EBM: Evidence - Evidence Evaluation | M. Makowsky |
| PHARM 413 | Y3 | Winter | 2025-01-20 | Lecture | Group development, dynamics | Behaviour: Group formation | T. Makinova |
| PHARM 413 | Y3 | Winter | 2025-01-20 | Seminar/case session | Pharmacy Environment | BASE: Project - Team Planning, Practice Setting, and Stakeholder Survey | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-01-22 | Lecture | Evaluating Evidence for Pharmacy Services | EBM: Evidence - Evidence Evaluation | M. Makowsky |
| PHARM 413 | Y3 | Winter | 2025-01-24 | Laboratory | Project Open time - Instructor Available | BASE: Project | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-01-27 | Lecture | Incorporating Evidence: Application | EBM: Evidence - Incorporating evidence | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-01-29 | Lecture | Ethics/Regulations for New Services | Administrative: Jurisprudence - Standards of Practice, Ethical Decision Making | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-01-31 | Lecture | Policy Change and Updates | Administration: Leadership - Building partnerships, forms of coalitions, people-centered care | K. Moran |
| PHARM 413 | Y3 | Winter | 2025-02-03 | Seminar/case session | New Service Options | BASE: Project - SWOT Analysis, Project Goal, Service Options | T. Makhinova/ J.Shkrobot/ |
| PHARM 413 | Y3 | Winter | 2025-02-03 | Lecture | New Services into Workflow | Adminstration: Practice change - Workflow Models, Workflow Analysis | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-02-05 | Lecture | Team Roles & Readiness | Adminstration: Practice change - Human Rescources. Assessment of Readiness. Role Delegation | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-02-07 | Laboratory | Project Open time - Instructor Available | BASE: Project | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-02-10 | Lecture | Marketing Pharmacy Services | Adminstration: Marketing - 4Ps with Application to Pharmacy Services | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-02-12 | Lecture | Personal Selling and Talking about Services | Behaviour: Communication - Personal Selling, Patient Care as Business Model | L. Guirguis |
| PHARM 413 | Y3 | Winter | 2025-02-14 | Lecture | Financial Sustainability | Administrative: Business planning - Income statement/balance sheet changes/analysis of cash flow | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-02-24 | Lecture | Financial Sustainability #2 | Administrative: Business Planning - practical implications | M. Bearisto |
| PHARM 413 | Y3 | Winter | 2025-02-24 | Seminar/case session | New Service Delivery | BASE: Project - Workflow, learning needs and materials | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-02-26 | Lecture | Program Evaluation and Pharmacy Practice Research | EBM: Program Evaluation & Research - Program Eval vs Research | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-02-28 | Lecture | Program Evaluation and Quality Improvement | EBM: Program Evaluation & Research - SPO model, quality indicators | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-03 | Lecture | Program Evaluation and Research: Outcomes | EBM: Program Evaluation & Research - ECHO Model, Patient Satisfaction | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-05 | Lecture | Program Evaluation and Research: Data collection and analysis | EBM: Program Evaluation & Research - Sources of data, interviews, surveys, ethical consideration | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-07 | Laboratory | Project Open time - Instructor Available | BASE: Project | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-10 | Seminar/case session | Marketing and Sustainability | BASE: Project - Marketing Plan and Sustainability , Teamwork Review | T. Makhinova/ J.Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-03-10 | Lecture | Program Evaluation and Research: Data analysis and reporting | EBM: Program Evaluation & Research - Descriptive and inferential statistics, statistical analysis plan | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-12 | Lecture | Implementation of new service | EBM: Program Evaluation & Research - Implementation science, implementation framework | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-14 | Lecture | Leadership 4: Leadership Placement | Administration: Leadership - Placement opportunities | AHS TBA |
| PHARM 413 | Y3 | Winter | 2025-03-17 | Lecture | Tips on Writing Executive Summary | BASE: Project | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-19 | Lecture | Application of privacy legislation to the implementation of patient care services | Adminstration: Jurisprudence - Health Information Act, Privacy Impact Assessments | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-03-21 | Laboratory | Project open time - Instructor Available | BASE: Project | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-24 | Lecture | Leadership 5: Women in Leadership | Administrative: Leadership - Women leadership | A. Oliver |
| PHARM 413 | Y3 | Winter | 2025-03-24 | Seminar/case session | Program Evaluation and Risk Mitigation | BASE: Project - Evaluation strategy, Risks and mitigation | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-03-26 | Laboratory | Project open time - Instructor Available | BASE: Project | T. Makhinova |
| PHARM 413 | Y3 | Winter | 2025-04-02 | Lecture | New Pharmacy Service Presentations 1 | BASE: Project - Three Student Group Presentations | BASE team |
| PHARM 413 | Y3 | Winter | 2025-04-03 | Lecture | New Pharmacy Service Presentations 2 | New Pharmacy Service Presentations 2 | BASE Team |
| PHARM 413 | Y3 | Winter | 2025-04-04 | Lecture | New Pharmacy Service Presentations 3 | BASE: Project - Three group presentations | BASE team |
| PHARM 413 | Y3 | Winter | 2025-04-07 | Lecture | New Pharmacy Service Presentations 4 | BASE: Project - Three Student Group Presentations | BASE team |
| PHARM 413 | Y3 | Winter | 2025-04-07 | Lecture | New Pharmacy Service Presentations 5 | BASE: Project - Three Student Group Presentations | BASE team |
| PHARM 413 | Y3 | Winter | 2025-04-07 | Lecture | New Pharmacy Service Presentations 6 | New Pharmacy Service Presentations 6 | BASE team |
| PHARM 413 | Y3 | Winter | 2025-04-07 | Seminar/case session | Timelines and Ex Summary | BASE Project: Timeline, Executive Summary | T. Makhinova/ J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2025-04-09 | Lecture | Wrap-Up and Evalution | BASE: course evaluation | BASE team |
Assessment Information
| PHARM 212 | Y1 | Final | Final exam | 55% | — |
| PHARM 212 | Y1 | Midterm | Midterm exam | 29% | — |
| PHARM 212 | Y1 | Seminars 1-6 | Participation/professionalism | 0% | — |
| PHARM 212 | Y1 | eClass Quizzes (4% each) | Quiz | 16% | — |
| PHARM 213 | Y1 | EBCP Literacy Assignment | Assignment/written work | 10% | — |
| PHARM 213 | Y1 | Final Exam | Final exam | 45% | — |
| PHARM 213 | Y1 | Midterm Exam | Midterm exam | 25% | — |
| PHARM 213 | Y1 | Seminars | Other/unspecified | 0% | — |
| PHARM 213 | Y1 | Quizzes | Quiz | 20% | — |
| PHARM 312 | Y2 | Evidence Appraisal | Assignment/written work | 20% | — |
| PHARM 312 | Y2 | Final Exam | Final exam | 35% | — |
| PHARM 312 | Y2 | Midterm Exam | Midterm exam | 35% | — |
| PHARM 312 | Y2 | Seminar | Other/unspecified | 0% | — |
| PHARM 312 | Y2 | Quizzes | Quiz | 10% | — |
| PHARM 313 | Y2 | Final Exam | Final exam | 39% | — |
| PHARM 313 | Y2 | Midterm Exam | Midterm exam | 31% | — |
| PHARM 313 | Y2 | Quiz #1 | Quiz | 6% | — |
| PHARM 313 | Y2 | Quiz #2 | Quiz | 6% | — |
| PHARM 313 | Y2 | Quiz #3 | Quiz | 6% | — |
| PHARM 313 | Y2 | Quiz #4 | Quiz | 6% | — |
| PHARM 313 | Y2 | Quiz #5 | Quiz | 6% | — |
| PHARM 412 | Y3 | Brief Lecture Critical Reflections (BCRs) | Assignment/written work | 24% | — |
| PHARM 412 | Y3 | Health Advocacy Project | Assignment/written work | 30% | — |
| PHARM 412 | Y3 | Final | Final exam | 30% | — |
| PHARM 412 | Y3 | Seminar Attendance | Participation/professionalism | 0% | — |
| PHARM 412 | Y3 | Quizzes | Quiz | 14% | — |
| PHARM 413 | Y3 | Brief Critical Reflection (lecture) | Assignment/written work | 5% | — |
| PHARM 413 | Y3 | Implementation Plan Presentation | Assignment/written work | 20% | — |
| PHARM 413 | Y3 | Individual Leadership Reflection | Assignment/written work | 10% | — |
| PHARM 413 | Y3 | New Patient Care Service Implementation Plan | Assignment/written work | 30% | — |
| PHARM 413 | Y3 | Peer evaluation and Teamwork | Other/unspecified | 15% | — |
| PHARM 413 | Y3 | Seminar | Other/unspecified | 0% | — |
| PHARM 413 | Y3 | Quiz 1 | Quiz | 6% | — |
| PHARM 413 | Y3 | Quiz 2 | Quiz | 7% | — |
| PHARM 413 | Y3 | Quiz 3 | Quiz | 7% | — |
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 212 — BASE 1 | Y1 | Fall | 43 | 0 | 0 | Final exam (1); Midterm exam (1); Participation/professionalism (2); Quiz (1) | This is the first in a series of courses delivered over three years of the program that introduces students to behavioral, administrative, social and evidence-based pharmacy. Topics covered include the pharmacist's role, drug use control, the health care system, and the patient's medication experience. Students will develop skills in answering health and medication related questions using evidence-based approaches. |
| PHARM 213 — BASE 2 | Y1 | Winter | 37 | 6 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | This is the second in a series of courses delivered over three years of the program that introduces students to behavioral, administrative, social, and evidence-based pharmacy. This course introduces students to the application of jurisprudence and a psychosocial approach to pharmacy. Students will develop skills in personal self-management, leadership, and evaluating experimental and observational study designs. (Restricted to Pharmacy students.) |
| PHARM 312 — Behavioral, Administrative, Social, and Evidence-based Pharmacy 3 | Y2 | Fall | 37 | 9 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Participation/professionalism (2); Quiz (1) | This is the third in a series of 6 courses delivered over three years of the program that introduces students to behavioral, administrative, social and evidence-based pharmacy. Building on BASE 1 and 2, the main focus of this course is to broaden perspectives on being a pharmacist, with a focus on pharmacy organizations and the communities in which they reside. *3 (fi6) (first term, 3-1-0). Students will apply ethical frameworks, the legal system, and roles of pharmacy organizations in pharmacy practice. Students will develop skills in creating educational plans, appraising randomized controlled trials, and using written patient information. (Restricted to Pharmacy students). |
| PHARM 313 — Behavioural, Administrative, Social, and Evidence-based Pharmacy 4 | Y2 | Winter | 37 | 6 | 0 | Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | ✪ 3 (fi 6) (second term, 3-1s-0) Topics covered include application of pharmacy practice management and patient safety culture to pharmacy practice across settings. Skill development in engaging with patients' specific cultural or communication needs, working in groups, shared decision making, and appraising synthesized resources and observational research. |
| PHARM 412 — Behavioural, Administrative, Social, and Evidence-based Pharmacy 5 | Y3 | Fall | 30 | 10 | 0 | Assignment/written work (5); Final exam (1); Participation/professionalism (1); Quiz (1) | Students will differentiate levels of care in the health care system and plan to advocate for patient needs. Students will apply laws and jurisprudence to complex practice issues. Skill development in preceptorship, self-directed learning, managing sensitive topics, evaluating clinical practice guidelines, pharmacoeconomic studies, qualitative research, and diagnostic tests. (Restricted to Pharmacy students.) |
| PHARM 413 — PHARM 413 - BASE 6 | Y3 | Winter | 34 | 6 | 5 | Assignment/written work (4); Participation/professionalism (2); Quiz (3) | 3 credits (fi 6) (second term, 3-1s-0) Students will design, plan, and evaluate a new pharmacy service drawing on expertise in behavioural, administrative, social and evidence-based pharmacy. Students will learn to integrate fundamental topics including: business planning, program evaluation, social theory, and pharmacy practice research. (Restricted to Pharmacy students.) Base 6 will provide you with the opportunity to apply your skills and knowledge to create an Implementation Plan for a New Patient Care Service. Seminar and lecture time will be used to lead you through a stepwise planning process. You will receive regular feedback and course time to develop your Patient Care Service. There is no midterm or final. In place, you will complete seminar activities, a presentation, and a written assignment. We are excited for you to put your BASE-ic learning into action. |
Session Information
| PHARM 212 | Y1 | Fall | 2025-09-03 | Lecture | Intro to BASE | Structure, Theory, and Model of BASE | BASE Team |
| PHARM 212 | Y1 | Fall | 2025-09-05 | Lecture | Learning and Teamwork | S.A.L.A.M.I., Working as a team | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-08 | Lecture | The Profession of Pharmacy | Profession, Professionalism, Professional Identity. | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-09 | Lecture | Pharmacist's Role - Teamwork expectations | Team Rules, Expectations, and Logo; Group Work | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-09 | Lecture | Regulatory Framework - Part 1 | Legislative Framework that Governs Pharmacy Practice (Federal, Provincial, ACP) | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-10 | Lecture | Regulatory Framework - Part 2 | Legislative Framework that Governs Pharmacy Practice (Federal, Provincial, ACP) | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-12 | Lecture | Patient Assessment - Part 1 | Patient Care Process, Assessment - SOP (Domain 3, 4, 7), Collecting appropriate information; documenting appropriate information | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-15 | Lecture | Patient Assessment - Part 2 | Patient Care Process, Assessment - SOP (Domain 7), Collecting appropriate information; documenting appropriate information | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-17 | Lecture | Medication Use Process - Dispensing - Part 1 | Drug Distribution / Dispensing - SOP (Domain 8), Regulatory requirements of a prescription, the dispensing process | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-19 | Lecture | Medication Use Process - Dispensing - Part 2 | Drug Distribution / Dispensing - SOP (Domain 8), Regulatory requirements of a prescription, the dispensing process | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-22 | Lecture | Documenting Prescription Order Activities - Part 1 | Requirements of patient care records, clarifying and requesting missing information | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-23 | Lecture | Practice Expectations | Practice Expectations | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-24 | Lecture | Documenting Prescription Order Activities - Part 2 | Written, verbal, faxed, e-prescriptions. Transferring prescriptions. | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-09-26 | Lecture | Ethics and the pharmacy profession | ACP Code Of Ethics, Autonomy, Beneficence, Nonmaleficence, Informed Consent | J. Hopwood-Raja |
| PHARM 212 | Y1 | Fall | 2025-09-29 | Lecture | Professional Discipline Process (ACP) | Discipline Process, Mitigating Errors | J. Krempien |
| PHARM 212 | Y1 | Fall | 2025-10-01 | Lecture | Prescription pricing model and drug benefit insurance principles. | Prescription drug pricing and the insurance model for prescription drug benefits | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-10-03 | Lecture | Introduction to the BASE Evidence Stream | Overview of BASE Evidence Curriculum, Evidence Based Clinical Practice, Drug Information, & Health Informatics | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2025-10-06 | Lecture | Introduction to Evidence Based Clinical Practice | EBCP Principles, EBCP Process, Smoking cessation, Foreground questions, Acquiring evidence, Appraising evidence, Applying evidence, Drug Dosing Resources, Consumer Health Apps, Patient Care Process. | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2025-10-08 | Lecture | Introduction to Drug Information | Role of the pharmacist in drug information, Primary Secondary & Tertiary Literature, Lexicomp, IV Compatibility, Drug Interactions, Dynamed | K. Sorensen |
| PHARM 212 | Y1 | Fall | 2025-10-10 | Lecture | Drug Information Resources | Canadian Product Monograph, CPS, Drug Product Database, Compendium of therapeutic choices, Compendium of products for minor ailments, Compendium of therapeutic choices for minor ailments, TRC Natural Medicines, Natural Health Product Database, Embase, Rxfiles | K. Sorensen |
| PHARM 212 | Y1 | Fall | 2025-10-14 | Lecture | Introduction to Drug Information Resources (J. Kung) | Evaluating the credibility of online health/drug/pharmacy resources; Finding/Using Summary Resources | J. Kung |
| PHARM 212 | Y1 | Fall | 2025-10-15 | Lecture | Systematic Approach to Drug Information | Systematic Approach to Answering Drug Information Questions, Collecting information, Classifying Drug Information requests, Formulating questions, Search Strategy, Communicating responses, Documentation | F. Yallou |
| PHARM 212 | Y1 | Fall | 2025-10-17 | Lecture | Information Mastery, Using Information Resources at the Point of Care | Knowledge based information resources, Hunting tools, Gathering tools, Usefulness Equation, Characteristics of high quality resources, Go To Information Resources | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2025-10-20 | Lecture | Accessing High Quality Evidence in Practice: Overview of the 6S Approach | What is evidence, Rationalism vs. Empiricism, Evidence Hierarchy, 6S Hierarchy of EBM Resources, Studies, Synopses, Syntheses, Summaries, Systems. | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2025-10-22 | Midterm exam | Midterm | Midterm | BASE Team |
| PHARM 212 | Y1 | Fall | 2025-10-24 | Lecture | Clinical Practice Guidelines 101 | Clinical Practice Guidelines: history, purpose, definition, & role. Acquiring CPGs, CPG guideline recommendations, What makes a guideline evidence based? Grades of recommendations, Issues in applying recommendations in practice, Tools to evaluate the Quality of a CPG. | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2025-10-27 | Lecture | Systematic Reviews 101 | Typology of Review Articles, Narrative Review, Systematic Review, Systematic Review & Meta-Analysis, Reading a Meta graph/Forrest Plot, Network meta-analysis, Umbrella review, Issues in applying evidence from systematic reviews in practice, Tools to appraise quality of Systematic reviews | M. Makowsky |
| PHARM 212 | Y1 | Fall | 2025-10-28 | Lecture | Indigenous Health and Pharmacy | Indigenous terminology, Indian Status in Canada, Treaty, Historical atrocities, Colonization on healthcare system and Indigenous Peoples, Moving forward | A. Ruben |
| PHARM 212 | Y1 | Fall | 2025-10-29 | Lecture | Core Communication Skills | Listening, Question Asking, Non-verbal Communication, Probes; | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-10-31 | Lecture | The Medication Experience | Medication Experience | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-11-03 | Other/unspecified | Debrief of Community Pharmacy Visit | Professional identity formation | J. Hall, J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-11-05 | Lecture | Gathering a Patient History | Flexible Structure, Time Management, Question Types | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-11-07 | Lecture | Harnessing Empathy | Empathetic Responding, Building Rapport | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-11-17 | Lecture | Monitoring Medications | Questions asking, non-adherence, direct and non-threatening strategies | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-11-18 | Lecture | Ethical principles in practice | Argue both sides of an ethical issue using ethical principles from the Alberta College of Pharmacists Code of Ethics. | J. Shkrobot, J. Krempien, J. Whissell |
| PHARM 212 | Y1 | Fall | 2025-11-19 | Lecture | Professional Communication with Emotional Patients | Communicating With Emotional Patients; Assertive Communication | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-11-21 | Lecture | Communicating with Children | Pediatrics, Swallowing Pills, Reporting Child Abuse, Age-Specific Strategies, Age-Specific Medication Needs | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-11-24 | Lecture | How can sociology help pharmacists? | Structure, Agency, Sociology, Power/Privilege, Iatrogenesis, Medicalization, Medical Gaze | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-11-26 | Lecture | Medication Taking Theory | Theory of Adherence vs. Compliance, Intelligent Noncompliance, Necessity-Concerns Framework, WHO adherence model | L. Guirguis |
| PHARM 212 | Y1 | Fall | 2025-11-28 | Lecture | Social Determinants of Health (SDoH) | Social Determinants of Health, Health Equity, Social Gradient, Health in all Policies | K. Watson |
| PHARM 212 | Y1 | Fall | 2025-12-01 | Lecture | Social Determinants of Health (SDoH) | Social Determinants of Health, Poverty: A Clinical Tool for Primary Care Providers | K. Watson |
| PHARM 212 | Y1 | Fall | 2025-12-02 | Lecture | EDI - Practice Expectations | Equity, Diversity and Inclusivity - Dealing with racism towards people of colour | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-12-03 | Lecture | Effective Team Management - Part 1 | Application of team skills | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-12-05 | Lecture | Effective Team Management - Part 2 | Application of team skills | J. Shkrobot |
| PHARM 212 | Y1 | Fall | 2025-12-08 | Lecture | Wrap-Up Lec | Wrap-Up, Course Evaluation | BASE Team |
| PHARM 213 | Y1 | Winter | 2025-01-06 | Lecture | Health Literacy I | Behaviour - Health literacy criteria, identification, strategies | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-08 | Lecture | Health Literacy II | Behaviour - Health literacy | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-10 | Lecture | Individual Patient Education | Behaviour - Educational strategies - verbal and written; tailoring, readability, chunking, teach-back | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-13 | Lecture | Written Materials | Behaviour - Plain language and readability | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-14 | Seminar/case session | Educational Materials Seminar | Behaviour - Teach-back | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-15 | Lecture | Communicating Risk About Medications | Behaviour - Visual/oral communication; palling palettes, odds, direction | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-17 | Lecture | Patient-Centred Interviewing | Patient centred communication, identifying goals, transitions and signposts | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-01-20 | Lecture | Introduction to Jurisprudence & Jurisprudence I | Administration - Food and Drugs Act/Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-22 | Lecture | Federal Jurisprudence II | Administration - Food and Drugs Act/Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-24 | Lecture | Federal Jurisprudence III | Administration - Controlled Drugs and Substances Act/Regulations/Schedules | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-27 | Lecture | Federal Jurisprudence IV | Administration - Part G & J of the Food and Drugs Act/Tracked Prescription Program | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-28 | Seminar/case session | Tracked Prescription Program Seminar | Administration - Narcotic Regulation Practice Cases, Administration - Tracked Prescription Program | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-29 | Lecture | Drug Diversion and Robbery Prevention | Administration - Drug Diversion and Robbery Prevention Techniques | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-01-31 | Lecture | Substance Abuse by Pharmacists | Administration - Abuse of Substances by Pharmacists | J. Krempien |
| PHARM 213 | Y1 | Winter | 2025-02-03 | Lecture | Provincial Jurisprudence I | Administration - Health Professions Act/Pharmacy and Drug Act | B. Willsey, D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-05 | Lecture | Provincial Jurisprudence II | Administration - Health Information Act | B. Willsey, D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-06 | Lecture | Provincial Jurisprudence III | Administration - ACP Guidance | B. Willsey/D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-07 | Lecture | Drug Scheduling | Administration - Drug Scheduling | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-10 | Lecture | Jurisprudence Application | Administration - Drug Scheduling Application, Administration - Legislation Application | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-12 | Lecture | Additional Jurisprudence Topics | Administration - Other HCP Regulations | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-14 | Lecture | ACP Standards of Practice | Administration - ACP Standards of Practice, Administration - Pharmacist Prescribing | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-24 | Lecture | Fostering a Culture of Patient Safety | Administration - Patient Safety | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-02-25 | Seminar/case session | Jurisprudence Seminar | Administration - Jurisprudence Cases | J. Krempien, J. Whissell |
| PHARM 213 | Y1 | Winter | 2025-02-26 | Lecture | Disclosure of Medical Errors | Behaviour - Strategies for disclosing errors | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-02-28 | Lecture | Evidence Literacy | Evidence - Reading a trial, synopsis | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-04 | Seminar/case session | Finding Studies & Synopses Seminar | Evidence - Evidence Literacy Seminar | J. Kung/M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-05 | Lecture | Trial Designs | Evidence - Overview of experimental and observational designs & introduction to RCTs | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-07 | Lecture | Evidence and Drug Development | Evidence - Drug policy and review process | S. Alsaadi |
| PHARM 213 | Y1 | Winter | 2025-03-10 | Lecture | Study Results I | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-12 | Lecture | Study Results II | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-14 | Lecture | Study Results III | Evidence - Define ARR, RR, RRR, NNT, NNH, OR | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-17 | Lecture | Confidence Intervals | Evidence - Confidence Intervals | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-18 | Seminar/case session | Journal Club Seminar | Evidence - Topics listed on eClass | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-19 | Lecture | Measuring Patient Experiences | Evidence - Continuous data (Scales); Comparison of 2 Means; Comparison of 2 Proportions; Power and Sample Size | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-21 | Lecture | Meta Analysis Results | Evidence - Forest plot, pooled OR, SMD, WMD | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-24 | Lecture | Time to Event Outcomes, Survival Analysis, & Hazard Ratios | Evidence - Hazard Ratios, time to event, and survival analysis | M. Makowsky |
| PHARM 213 | Y1 | Winter | 2025-03-26 | Lecture | BASE Flex Lecture | Addressing Student Learning Needs | D. Moulton |
| PHARM 213 | Y1 | Winter | 2025-03-28 | Lecture | Talking About Change: Smoking Cessation | Behaviour - Transtheoretical Model | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-03-31 | Lecture | Leading Self | Behaviour - Leading Self | T. Makhinova |
| PHARM 213 | Y1 | Winter | 2025-04-01 | Seminar/case session | Leading Self Seminar | Behaviour - Leading Self | T. Makhinova |
| PHARM 213 | Y1 | Winter | 2025-04-02 | Lecture | Professional Learning | Behaviour - Professional Learning | P. Timanson |
| PHARM 213 | Y1 | Winter | 2025-04-04 | Lecture | Continuing Professional Development | Behaviour - CPD Process, ACP Continuing Competence Program | P. Timanson |
| PHARM 213 | Y1 | Winter | 2025-04-07 | Lecture | Communicating with Children | Behaviour - Communicating with children | L. Guirguis |
| PHARM 213 | Y1 | Winter | 2025-04-09 | Final exam | BASE Wrap-Up, SPoT Survey, & Final Exam Review | BASE - Review, wrap up | All Lecturers |
| PHARM 312 | Y2 | Fall | 2025-09-03 | Lecture | Course Intro/Healthcare Resources | Course Overview, Canada Health Act, Accreditation Canada, College of Physicians & Surgeons of Alberta, Patient & Public Involvement in Healthcare, Cost of Healthcare resources | M. Makowsky/J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2025-09-05 | Lecture | Provision of Healthcare Services | Public Health (PHAC). Emergency Care. Primary/Ambulatory Care. Inpatient/Specialized Care. Homecare. Long-term care. Rehabilitation.Palliative Care. Mental Health. Dental Care. Complementary & Alternative Medicine. First Nations and Inuit Health Services | J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2025-09-08 | Lecture | Health system organizations | Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), Canadian Institute for Health Information (CIHI), Alberta Health (AH), Alberta Health Services (AHS), Health Quality Council of Alberta (HQCA), Canadian Pharmacists Association (CPhA), Neighbourhood Pharmacy Association of Canada, Canadian Society of Hospital Pharmacists (CSHP), Alberta College of Pharmacy (ACP), Alberta Pharmacists' Association (RxA) | J. Shkrobot |
| PHARM 312 | Y2 | Fall | 2025-09-10 | Lecture | Medication Use Process in the Hospital Setting (1) | Mission & Vision of AHS Pharmacy Services, Medication Distribution Systems, Automated Dispensing cabinets, Unit Dose, Bulk Tablet Repackaging, Centralized IV Additive Service, Direct Patient Care Service, Medication Safety | K. Olstead |
| PHARM 312 | Y2 | Fall | 2025-09-12 | Lecture | Medication Use Process in the Hospital Setting (2) | Connect Care/EPIC, Medication Reconciliation, Antimicrobial Stewardship, Drugs and Therapeutics Committee, Backorder & Shortage management, Parenteral monographs, Barcoding, Closed Loop medication management | K. Olstead |
| PHARM 312 | Y2 | Fall | 2025-09-15 | Lecture | ADR Reporting in Hospital | Mandatory Reporting for Hospitals, Vanessa's Law, Process for reporting serious ADRs in AHS facilities | K. Popovic/B. Coulton |
| PHARM 312 | Y2 | Fall | 2025-09-17 | Lecture | Hospital Pharmacists' Role as Educator | Skills & Knowledge required to educate groups of patients, Pharmacist experiences in providing group education, Benefits of group education for patients. | T. Schindel |
| PHARM 312 | Y2 | Fall | 2025-09-18 | Seminar/case session | Developing Education Plans for Groups of Patients | Creating an Education Plan | T. Schindel |
| PHARM 312 | Y2 | Fall | 2025-09-19 | Lecture | Basics of Learning Theories: Supporting your Role as Educator | Learning Theory; Theoretic frameworks (Behaviourism, humanism, cognitivism, social cognitive, constructivism, critical) | T. Schindel |
| PHARM 312 | Y2 | Fall | 2025-09-22 | Lecture | Designing and Evaluating Education | ADDIE Framework; SMART objectives, Bloom's Taxonomy; Formative & Summative Assessment, Program Evaluation | T. Schindel |
| PHARM 312 | Y2 | Fall | 2025-09-24 | Lecture | Cultural Safety - An Indigenous Lens (1) | Health Equity, Cultural Safety | A. Ruben |
| PHARM 312 | Y2 | Fall | 2025-09-26 | Lecture | Cultural Safety - An Indigenous Lens (2) | Health Equity, Cultural Safety | A. Ruben |
| PHARM 312 | Y2 | Fall | 2025-09-29 | Lecture | Introduction to the Legal System/The Alberta Court System | Law, Legal system, Institutions of law, Sources of law, Types of legal actions, Canadian Court System, Alberta Court System | M. Yu |
| PHARM 312 | Y2 | Fall | 2025-10-01 | Lecture | Legal Obligations of Regulated Health Care Professionals | Courts vs. Regulators, Regulatory Tools, Professional Liability Insurance, Continuing competence, Breach of Standards of Practice, Drug Diversion, Record Keeping, Character & Reputation | C. Bailey |
| PHARM 312 | Y2 | Fall | 2025-10-02 | Lecture | Privacy Law (Part 1) | FOIPPA, PIPEDA, CASL, PIPA, HIA, Personal Information, Collection, Use, Disclosure | M. Yu |
| PHARM 312 | Y2 | Fall | 2025-10-02 | Lecture | Privacy Law (Part 2) | Health Information Act- Use, Disclosure, Breach, Compliance | M. Yu |
| PHARM 312 | Y2 | Fall | 2025-10-03 | Lecture | Consent & Informed Consent | Voluntary Consent, Capacity (Adults, minors), Elements of Informed Consent | C. Bailey |
| PHARM 312 | Y2 | Fall | 2025-10-06 | Lecture | Law of Negligence: Duty & Standard of Care | Torts, Negligence, Duty of care, Standard of care | M. Jackson |
| PHARM 312 | Y2 | Fall | 2025-10-08 | Lecture | Law of Negligence: Causation & | Factual & Legal Causation, Reasonable Foreseeability | M. Jackson |
| PHARM 312 | Y2 | Fall | 2025-10-10 | Lecture | Law of Negligence: Causation & Damages (1) | Damages and forms of compensation, Pecuniary Damages, Non-pecuniary Damages | M. Jackson |
| PHARM 312 | Y2 | Fall | 2025-10-13 | No class | Thanksgiving - No Class | Thanksgiving - No Class | — |
| PHARM 312 | Y2 | Fall | 2025-10-14 | Lecture | Law of Negligence: Defences | Contributory negligence, Voluntary assumption of risk, Illegality, Expiration of time limit for instituting a legal action | M. Jackson |
| PHARM 312 | Y2 | Fall | 2025-10-14 | Lecture | Medical Assistance In Dying: Legal Framework & Pharmacist Role | Federal Legislation for MAID, Truchon vs. Procureur, AHS MAID Policy, Track 1 vs. Track 2 | C. Bailey |
| PHARM 312 | Y2 | Fall | 2025-10-15 | Seminar/case session | Law Seminar (Part 1) | Negligence, Privacy Law | M. Yu |
| PHARM 312 | Y2 | Fall | 2025-10-16 | Other/unspecified | Hospital Pharmacy Site Visits (Timeslot 1) | Hospital Medication Use Process, Introduction to Patient Care Unit, Overview of Hospital Clinical Pharmacist Roles | — |
| PHARM 312 | Y2 | Fall | 2025-10-17 | Seminar/case session | Law Seminar (Part 2 - Debreif) | Negligence, Privacy Law | M. Yu |
| PHARM 312 | Y2 | Fall | 2025-10-20 | Other exam/test | Pharmacogenomic Testing: Ethical & Legal Considerations | Personalized & Precision Medicine, Fundamentals of Genetics (Genotype, Phenotype), Informed Consent for PGx testing, Privacy, Genetic information Nondiscrimination Act | D. El Sayed |
| PHARM 312 | Y2 | Fall | 2025-10-22 | Lecture | Introduction to Critical Appraisal of a RCT | Assessing Cause & Effect, JAMA Approach to Critical Appraisal of a Therapy Study, Strategies to reduce Bias, Steps to practice EBM, Using Pre-Appraised Resources, Bias & Random Error | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-10-23 | Other/unspecified | Hospital Pharmacy Site Visits (Timeslot 2) | Hospital Medication Use Process, Introduction to Patient Care Unit, Overview of Hospital Clinical Pharmacist Roles | — |
| PHARM 312 | Y2 | Fall | 2025-10-24 | Lecture | Appraisal of a RCT - Assessing Risk of Bias II | Randomization, Allocation concealment, Balancing prognostic factors | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-10-27 | Midterm exam | MIDTERM EXAM | Lectures & Seminars up to and including October 17th | — |
| PHARM 312 | Y2 | Fall | 2025-10-28 | Lecture | Appraisal of a RCT - Risk of Bias III | Blinding, Loss to followup | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-10-28 | Lecture | Appraisal of a RCT - Risk of Bias IV | Intention to Treat Analysis, Per Protocol Analysis, On Treatment analysis, Stopping Rules, Funding Bias | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-10-29 | Lecture | Appraisal of a RCT - Study Results & Application to Patient Care (1) | Magnitude & Precision of Effect, Internal & External validity, Subgroup analysis, Drug Class effects | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-10-30 | Other/unspecified | Hospital Pharmacy Site Visits (Timeslot 3) | Hospital Medication Use Process, Introduction to Patient Care Unit, Overview of Hospital Clinical Pharmacist Roles | — |
| PHARM 312 | Y2 | Fall | 2025-10-31 | Seminar/case session | Evidence Appraisal - RCT (Part 1) | Creating a Study Synopsis, Evidence Appraisal & Application to Patient care | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-11-03 | Seminar/case session | Evidence Appraisal - RCT (Part 2 - Debrief) | Creating a Study Synopsis, Evidence Appraisal & Application to Patient care | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-11-05 | Lecture | Critical Appraisal of a Non-Inferiority Trial | Superiority vs. Equivalence, vs. Non-inferiority, JAMA Approach to evaluating Non Inferiority Studies | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-11-07 | Lecture | Critical Appraisal of a Non-Inferiority Trial - Methodological Issues | Appropriate active control, Appropriate patients & Outcomes, Optimal application of treatment regimens, Intention to treat vs Per Protocol Analysis, Establishing the non inferiority margin, Sample size | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-11-10 | Lecture | FALL BREAK 1 | FALL BREAK 1 | — |
| PHARM 312 | Y2 | Fall | 2025-11-12 | Lecture | FALL BREAK 2 | FALL BREAK 2 | — |
| PHARM 312 | Y2 | Fall | 2025-11-14 | Lecture | FALL BREAK 3 | FALL BREAK 3 | — |
| PHARM 312 | Y2 | Fall | 2025-11-17 | Lecture | Hospital Pharmacy Visit - Debrief | Hospital Pharmacy Debrief | P. Gill |
| PHARM 312 | Y2 | Fall | 2025-11-19 | Other exam/test | Hypothesis Testing: Power & Sample Size | Study Power, Sample Size TBA | B. Vandermeer |
| PHARM 312 | Y2 | Fall | 2025-11-20 | Seminar/case session | Evidence Appraisal - RCT/NIFT | Evidence Appraisal - RCT/NIFT | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-11-21 | Lecture | Evaluation of Systematic Reviews - Search and Selection | Systematic Review, Meta analysis, Review Registration, PRISMA, Characteristics of a Credible review, Heterogeneity | S. Simpson |
| PHARM 312 | Y2 | Fall | 2025-11-24 | Lecture | Evaluation of Systematic Reviews - Data Abstraction and Analysis | Risk of Bias Assessment, Publication Bias, Sensitivity Analysis, Assessment of Heterogeneity, Fixed & Random Effects Models, Network Meta analysis | S. Simpson |
| PHARM 312 | Y2 | Fall | 2025-11-26 | Lecture | Finding the Best Evidence | Searching at the Point of Care, Systematic Literature Searching, PubMed | J. Kung |
| PHARM 312 | Y2 | Fall | 2025-11-28 | Seminar/case session | Contemporary Issues in Pharmacy Informatics (Part 1) | Privacy, Pharmacy & Social Media, Digital Health, Mobile Apps, Virtual Care | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-12-01 | Seminar/case session | Contemporary Issues in Pharmacy Informatics (Debrief) | Privacy, Pharmacy & Social Media, Digital Health, Mobile Apps, Virtual Care | M. Makowsky/J. Mutch |
| PHARM 312 | Y2 | Fall | 2025-12-03 | Lecture | Critical Appraisal of a study that measures patient experience | Instruments to measure health status, Attributes of high quality trials assessing health status, Face Validity, Content validity, Construct validity, Reliability, Responsiveness, Precision, Reproducibility, Internal consistency, Interpretability, Minimal Clinically Important Difference | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-12-04 | Seminar/case session | Evidence Appraisal - Systematic Reviews | Creating a Synopsis, Evidence Appraisal & Application to Patient care | S. Simpson |
| PHARM 312 | Y2 | Fall | 2025-12-05 | Lecture | Integrated Case Wrap Up Lecture: | TBA | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-12-08 | Final exam | Course Evaluation and Q&A | SPOT Course Evaluation, Final Exam Overview, Question & Answer | M. Makowsky |
| PHARM 312 | Y2 | Fall | 2025-12-10 | Final exam | FINAL EXAM | Lectures & Seminars from October 20th forward | — |
| PHARM 313 | Y2 | Winter | 2025-01-26 | Lecture | Pharmacoepidemiologic Study Designs Part 2: Cohort Studies | Cohort and nested case control studies; Advantages and limitations of study designs | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-01-05 | Lecture | Introduction, Practice shared decision making / risk communication | Evaluate approaches and tools to communicate risk to patients, Discuss how to prepare patients to participate in decisions, Compare types of patient decision aids | J. Shkrobot, L. Guirguis |
| PHARM 313 | Y2 | Winter | 2026-01-07 | Lecture | Practice shared decision making / risk communication | Describe the key principles of shared decision making, Compare shared decision making with traditional patient-clinician communication, Appreciate the patient’s experience and perspective in health care | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2026-01-09 | Lecture | Complex Communication - Working with people who do not communicate effectively in the English language | Identify strategies to provide patient centred care to individuals who speak a language other than English; Describe how pharmacy environments and education can be adapted for individuals with language barriers; Describe and evaluate resources for people with language barriers | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-01-12 | Lecture | Complex Communication - Working with people who have a disability | Identify strategies to provide patient centred care to individuals with disabilities; Describe how pharmacy environments and education can be adapted for individuals with disabilities; Describe and evaluate resources for people with disabilities | Voice of Albertans with Disabilities |
| PHARM 313 | Y2 | Winter | 2026-01-14 | Lecture | Introduction to Pharmacoepidemiology and Limitations of Premarket Evidence | Introduce pharmacoepidemiology and common epidemiological terms; Describe the link between pharmacoepidemiology and the patient care process. | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-01-15 | Seminar/case session | Shared decision making (Seminar) | Apply shared decision making principles and risk communication tools in decision making scenarios. | L. Guirguis |
| PHARM 313 | Y2 | Winter | 2026-01-16 | Lecture | Randomized Controlled Trials and Observational Studies - Why do we need both? | Compare major design elements of randomized controlled trials and observational studies; Define the terms efficacy, effectiveness, and drug safety; Describe advantages and limitations of RCTs and observational studies as sources of evidence for drug effectiveness and safety. | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-01-19 | Lecture | Adverse Drug Reaction Reporting and Drug Safety | Introduce fundamental principles when examining drug–outcome associations; Examine spontaneous adverse drug reaction reports and health care databases; Compare type A and type B drug reactions; Define safety signals and how generated. | K. Popovic |
| PHARM 313 | Y2 | Winter | 2026-01-21 | Lecture | Common Data Sources Used to Assess Drug Safety and Effectiveness | Define secondary analysis and highlight advantages and limitations; Describe how prospective cohorts and population-based surveys are used as data sources; List other commonly used data resources in pharmacoepidemiology studies. | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-01-23 | Lecture | Pharmacoepidemiologic Study Designs Part 1: Cross Sectional and Case-Control Studies | Describe major elements of Cross-Sectional and Case-Control Studies; Highlight advantages and limitations; Discuss example of a case-control study. | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-01-28 | Lecture | Defining Variables and Building a Case for Causality | Describe how to evaluate variable definitions; Define causal inference; Describe common considerations used in pharmacoepidemiology. | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-01-29 | Seminar/case session | EBM Seminar 1 - Searching for Drug Safety and Effectiveness Studies | Review the 6S hierarchy of medical evidence; Navigate available resources to find best evidence for patient care questions related to harm | J. Kung |
| PHARM 313 | Y2 | Winter | 2026-01-30 | Lecture | Bias in Pharmacoepidemiologic Studies | Describe how selection bias and information bias can affect observational studies | S. Hameed and S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-02-02 | Lecture | Confounding in Pharmacoepidemiologic Studies | Discuss confounding and how to minimize its effects in pharmacoepidemiologic studies | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-02-04 | Lecture | Statistical Analyses in Pharmacoepidemiologic Studies | Review common measurements of association used in pharmacoepidemiologic studies - Relative Measures / Absolute Measures / Hazard Ratio; Define common terms used in statistical analysis; Introduce effect modification and interaction | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-02-06 | Lecture | Other Applications of Pharmacoepidemiologic Studies | Describe major design elements of a drug utilization study; Illustrate how medication adherence can be assessed using pharmacoepidemiology methods; Questions from the class | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-02-09 | Lecture | Strategic Planning | Describe elements of a strategic plan; Demonstrate SWOT analysis; Compare competitive strategies used in pharmacy practice; Outline how SMART objectives are used in establishing goals | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-02-11 | Lecture | Change Management | Discriminate between risks associated with change and failing to change; Examine Kotter's eight-step model; Apply change management strategies to health team scenarios | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-02-12 | Seminar/case session | EBM Seminar 2 - Critical Appraisal of a Pharmacoepidemiologic Study | Evaluate and critically appraise observational research using the RECORD-PE review tool; Apply results of observational research to patient care questions | S. Simpson |
| PHARM 313 | Y2 | Winter | 2026-02-13 | Lecture | Planning and implementing patient care services | Describe pharmacy services that pharmacies provide; Describe best practices related to the patient experience; Describe how to complete a needs assessment; Predict barriers to new service implementation and create solutions; Describe performance measures to evaluate effectiveness | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-02-23 | Lecture | Older Adults, Ageism, and Age Friendly Practice | Define ageism; Describe the impact of ageism on older adults; Describe interventions to reduce ageism; List the 8 domains of liveability for Age-Friendly settings; Explain how Age-Friendly initiatives can be integrated into pharmacy practice | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-02-25 | Midterm exam | Midterm Exam | Midterm Exam | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-02-27 | Lecture | Role of Pharmacy Licensee - Part 1 | Describe regulatory requirements related to the role of the Pharmacy Licensee in Alberta; Classify responsibilities of a licensee compared to a pharmacist within a licensed pharmacy (including sexual abuse and misconduct, POCT, compounding) | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-02 | Lecture | Role of Pharmacy Licensee - Part 2 | Describe regulatory requirements related to the role of the Pharmacy Licensee in Alberta; Classify responsibilities of a licensee compared to a pharmacist within a licensed pharmacy (including sexual abuse and misconduct, POCT, compounding) | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-04 | Lecture | Role of Pharmacy Licensee - Part 3 | Describe regulatory requirements related to the role of the Pharmacy Licensee in Alberta; Classify responsibilities of a licensee compared to a pharmacist within a licensed pharmacy (including sexual abuse and misconduct, POCT, compounding) | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-05 | Seminar/case session | Case Studies - Change Management (Seminar) | Case Studies; Apply change management strategies to scenarios that may occur within a health team | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-06 | Lecture | Human resource management - Part 1 | Describe roles and responsibilities for human resource management; Demonstrate how Alberta employment legislation impacts pharmacists; Demonstrate how an employment relationship is terminated; Summarize differences between unionized vs non-unionized environments | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-09 | Lecture | Human resource management - Part 2 | Compare sourcing strategies to obtain applicants; Describe screening/evaluation processes for hiring; Summarize negotiating an offer and orientation/training best practices | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-11 | Lecture | Inventory management | Summarize basic principles of inventory management; Describe sources of inventory for pharmacies and determine advantages/disadvantages; Critique inventory management tools used in pharmacy practices | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-13 | Lecture | Pharmacy Compensation Framework - Part 1 | Distinguish between different types of pharmacy services; Identify criteria and understand billing framework for Alberta's compensation plan for pharmacy services; Identify non-Alberta government sponsored compensation programs | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-13 | Lecture | Pharmacy Compensation Framework - Part 2 | Distinguish between different types of pharmacy services; Identify criteria and understand billing framework for Alberta's compensation plan for pharmacy services; Identify non-Alberta government sponsored compensation programs | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-16 | Lecture | Errors in community and hospital settings - Part 1 | Explain how a culture of open acknowledgement of errors and learning from mistakes is critical to improving safety; Develop a plan for disclosure of a medication error; Analyze examples of medication errors | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-18 | Lecture | Errors in community and hospital settings - Part 2 | Describe what improvements can be made in the healthcare system and human functioning to avoid medical errors | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-19 | Seminar/case session | Case studies - Human resources management (Seminar) | Application of regulatory and best practices for human resource management issues. | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-20 | Lecture | Continuous Quality Improvement - Part 1 | Describe five key activities of the CQI+ program; Utilize CQI+ as a quality improvement process in case study examples. | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-23 | Lecture | Continuous Quality Improvement - Part 2 | Describe five key activities of the CQI+ program; Utilize CQI+ as a quality improvement process in case study examples. | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-25 | Lecture | Risk management | Define types of risks a pharmacy practice can be exposed to; Create a risk management plan using common strategies | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-27 | Lecture | Finance - Part 1 | Interpret sources of income and expenses; Interpret an income statement and how it measures performance; Interpret assets, liabilities and equity; Demonstrate how to determine gross profit and gross margin | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-03-30 | Lecture | Finance - Part 2 | Interpret a cash flow statement and key financial ratios to measure pharmacy performance | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-04-01 | Lecture | Marketing | Describe core marketing concepts as they relate to pharmacy; Apply the four 'P's of marketing; Deconstruct five stages of consumer behaviour; Describe market segmentation and branding as applied to pharmacy | J. Shkrobot |
| PHARM 313 | Y2 | Winter | 2026-04-02 | Seminar/case session | Peer Assisted Learning | Define the peer learning model and why it works; Discuss attributes of a good peer to optimize a PAL placement; Practice skills to be a good peer; Identify activities for peer on placement | P. Gill, M. MacDonald, S. Khurana, A. Chatterjee |
| PHARM 313 | Y2 | Winter | 2026-04-08 | Lecture | Grief in Pharmacy | Identify types of loss and loss experiences; Deepen understanding of grief reactions; Describe contemporary models of grief and ways of helping self and others | B. VanTassel |
| PHARM 313 | Y2 | Winter | 2026-04-10 | Lecture | Wrap Up Lecture | Wrap Up Lecture, Course Evaluation | J. Shkrobot |
| PHARM 412 | Y3 | Fall | 2025-09-03 | Lecture | BASE 5 Introduction | BASE 5 Introduction | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-09-05 | Lecture | Pharmacists’ Role in Public Health | Pharmacists’ Role in Public Health | K. Watson |
| PHARM 412 | Y3 | Fall | 2025-09-08 | Lecture | Design Thinking | Design Thinking | J. McCutcheon |
| PHARM 412 | Y3 | Fall | 2025-09-08 | Seminar/case session | Seminar 1 | Seminar 1 | — |
| PHARM 412 | Y3 | Fall | 2025-09-08 | Seminar/case session | Teamwork and Discover Phase | Teamwork and Discover Phase | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-09-10 | Lecture | CSL and the Health Advocacy Project | CSL and the Health Advocacy Project | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-09-12 | Lecture | Social Location and Reflection | Social Location and Reflection | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-09-15 | Other/unspecified | Community Partner (CP) Meeting 1 | Community Partner (CP) Meeting 1 | — |
| PHARM 412 | Y3 | Fall | 2025-09-15 | Other/unspecified | Meet your Community Partner (CP) | Meet your Community Partner (CP) | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-09-17 | Lecture | CP Meeting Debrief and Types of Advocacy | CP Meeting Debrief and Types of Advocacy | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-09-19 | Other exam/test | Advocacy Examples and Reflection Feedback | Advocacy Examples and Reflection Feedback | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-09-22 | Seminar/case session | Define Phase and Develop Phase | Define Phase and Develop Phase | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-09-22 | Lecture | Patient Advocacy | Patient Advocacy | B. Kidd |
| PHARM 412 | Y3 | Fall | 2025-09-22 | Seminar/case session | Seminar 2 | Seminar 2 | — |
| PHARM 412 | Y3 | Fall | 2025-09-24 | Lecture | Racism And Microaggressions In Healthcare | Racism And Microaggressions In Healthcare | N. Iroh |
| PHARM 412 | Y3 | Fall | 2025-09-26 | Lecture | Trauma Informed Care | Trauma Informed Care | G. Baehr |
| PHARM 412 | Y3 | Fall | 2025-09-29 | Lecture | Health and Wellness Resources for Indigenous Patients | Health and Wellness Resources for Indigenous Patients | A. Ruben |
| PHARM 412 | Y3 | Fall | 2025-10-01 | Other/unspecified | Community Partner (CP) Meeting 2 | Community Partner (CP) Meeting 2 | — |
| PHARM 412 | Y3 | Fall | 2025-10-01 | Lecture | Present and Select Ideas | Present and Select Ideas | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-10-03 | Lecture | History and Models/Theories of Substance Use | History and Models/Theories of Substance Use | E. Salokangas |
| PHARM 412 | Y3 | Fall | 2025-10-06 | Lecture | Principles to Providing Care to People Who Use Drugs | Principles to Providing Care to People Who Use Drugs | E. Salokangas |
| PHARM 412 | Y3 | Fall | 2025-10-06 | Seminar/case session | Select, Create and Reflect | Select, Create and Reflect | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-10-06 | Seminar/case session | Seminar 3 | Seminar 3 | — |
| PHARM 412 | Y3 | Fall | 2025-10-08 | Lecture | Professional Advocacy and Influencing (Cancelled) | Professional Advocacy and Influencing (Cancelled) | M. Tachuk |
| PHARM 412 | Y3 | Fall | 2025-10-10 | Lecture | Professional Advocacy and Influencing (Cancelled) | Professional Advocacy and Influencing (Cancelled) | M. Tachuk |
| PHARM 412 | Y3 | Fall | 2025-10-15 | Lecture | Advocacy with Intention (Asynchronous) | Advocacy with Intention (Asynchronous) | A. Goldblatt |
| PHARM 412 | Y3 | Fall | 2025-10-17 | Other/unspecified | HAP Teamwork Opportunity | HAP Teamwork Opportunity | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-10-17 | Other/unspecified | Teamwork Opportunity | Teamwork Opportunity | — |
| PHARM 412 | Y3 | Fall | 2025-10-20 | Lecture | Pharmacy and the Environment I | Pharmacy and the Environment I | K. Watson |
| PHARM 412 | Y3 | Fall | 2025-10-22 | Lecture | Pharmacy and the Environment II | Pharmacy and the Environment II | K. Watson |
| PHARM 412 | Y3 | Fall | 2025-10-24 | Lecture | Pharmacy and the Environment III | Pharmacy and the Environment III | K. Watson |
| PHARM 412 | Y3 | Fall | 2025-10-27 | Other/unspecified | Community Partner (CP) Meeting 3 | Community Partner (CP) Meeting 3 | — |
| PHARM 412 | Y3 | Fall | 2025-10-27 | Seminar/case session | Plan and Review | Plan and Review | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-10-27 | Seminar/case session | Seminar 4 | Seminar 4 | — |
| PHARM 412 | Y3 | Fall | 2025-10-27 | Other/unspecified | Share Prototype and Feedback | Share Prototype and Feedback | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-10-29 | Lecture | Home and Community Care | Home and Community Care | E. Duteau |
| PHARM 412 | Y3 | Fall | 2025-10-31 | Lecture | Continuing Care Homes | Continuing Care Homes | O. Nikolaev |
| PHARM 412 | Y3 | Fall | 2025-11-03 | Lecture | Pharmacoeconomics I | Pharmacoeconomics I | E. Kirwin |
| PHARM 412 | Y3 | Fall | 2025-11-05 | Lecture | Pharmacoeconomics II | Pharmacoeconomics II | E. Kirwin |
| PHARM 412 | Y3 | Fall | 2025-11-07 | Other/unspecified | HAP Teamwork Opportunity | HAP Teamwork Opportunity | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-11-07 | Other/unspecified | Teamwork Opportunity | Teamwork Opportunity | — |
| PHARM 412 | Y3 | Fall | 2025-11-17 | Seminar/case session | Health Advocacy Project Showcase | Health Advocacy Project Showcase | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-11-17 | Seminar/case session | Health Advocacy Project Showcase | Health Advocacy Project Showcase | — |
| PHARM 412 | Y3 | Fall | 2025-11-17 | Lecture | Pharmacoeconomics III (Asynchronous) | Pharmacoeconomics III (Asynchronous) | E. Kirwin |
| PHARM 412 | Y3 | Fall | 2025-11-17 | Lecture | Showcase Preparation/Final Group Meeting | Showcase Preparation/Final Group Meeting | D. Moulton |
| PHARM 412 | Y3 | Fall | 2025-11-17 | Other/unspecified | Teamwork Opportunity | Teamwork Opportunity | — |
| PHARM 412 | Y3 | Fall | 2025-11-19 | Lecture | Pharmacoeconomics IV | Pharmacoeconomics IV | E. Kirwin |
| PHARM 412 | Y3 | Fall | 2025-11-21 | Other exam/test | Diagnostic and Screening Tests | Diagnostic and Screening Tests | M. Makowsky |
| PHARM 412 | Y3 | Fall | 2025-11-24 | Lecture | De-Escalation Training | De-Escalation Training | A. Conway |
| PHARM 412 | Y3 | Fall | 2025-11-26 | Other exam/test | Diagnostic and Screening Tests | Diagnostic and Screening Tests | M. Makowsky |
| PHARM 412 | Y3 | Fall | 2025-11-28 | Other exam/test | Diagnostic and Screening Tests | Diagnostic and Screening Tests | M. Makowsky |
| PHARM 412 | Y3 | Fall | 2025-12-01 | Other exam/test | Diagnostic and Screening Tests | Diagnostic and Screening Tests | M. Makowsky |
| PHARM 412 | Y3 | Fall | 2025-12-03 | Lecture | Evaluate and Apply CPGs | Evaluate and Apply CPGs | S. Simpson |
| PHARM 412 | Y3 | Fall | 2025-12-05 | Lecture | Evaluate and Apply CPGs | Evaluate and Apply CPGs | S. Simpson |
| PHARM 412 | Y3 | Fall | 2025-12-08 | Lecture | Wrap Up and Course Evaluation | Wrap Up and Course Evaluation | D. Moulton |
| PHARM 413 | Y3 | Winter | 2025-01-12 | Seminar/case session | Pharmacy Environment | Pharmacy Environment | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2025-01-26 | Seminar/case session | New Service Options | New Service Options | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2025-02-09 | Seminar/case session | New Service Delivery | New Service Delivery | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2025-03-02 | Seminar/case session | Marketing and Sustainability | Marketing and Sustainability | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2025-03-16 | Seminar/case session | Program Evaluation and Risk Mitigation | Program Evaluation and Risk Mitigation | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2025-03-30 | Seminar/case session | Timelines and Ex Summary (1/2 Seminar 6) | Timelines and Ex Summary (1/2 Seminar 6) | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-01-05 | Lecture | Course and Project Overview | Course and Project Overview | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-01-07 | Lecture | Planning business and new service | Planning business and new service | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-01-09 | Lecture | *Leadership 1: Proactive engagement | Leadership 1: Proactive engagement | C. Oleksyn |
| PHARM 413 | Y3 | Winter | 2026-01-12 | Lecture | Leadership 2: Systems thinking | Leadership 2: Systems thinking | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-01-14 | Lecture | Evaluating Evidence for Pharmacy Services | Evaluating Evidence for Pharmacy Services | M. Makowsky |
| PHARM 413 | Y3 | Winter | 2026-01-16 | Lecture | Evaluating Evidence for Pharmacy Services | Evaluating Evidence for Pharmacy Services | M. Makowsky |
| PHARM 413 | Y3 | Winter | 2026-01-19 | Lecture | *Group development, dynamics | Group development, dynamics | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-01-21 | Lecture | Incorporating Evidence: Application | Incorporating Evidence: Application | F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-01-23 | Laboratory | Project Open Time - Instructor Available | Project Open Time | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-01-26 | Lecture | Ethics/Regulations for New Services | Ethics/Regulations for New Services | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-01-28 | Lecture | New Services into Workflow | New Services into Workflow | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-01-30 | Lecture | Policy Implications (ACP) | Policy Implications (ACP) | K. Morgan |
| PHARM 413 | Y3 | Winter | 2026-02-02 | Lecture | Team Roles & Readiness | Team Roles & Readiness | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-02-04 | Lecture | Marketing Pharmacy Services | Marketing Pharmacy Services | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-02-06 | Laboratory | Project Open Time - Instructor Available | Project Open Time | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-02-09 | Lecture | Program Evaluation and Pharmacy Practice Research | Program Evaluation and Pharmacy Practice Research | F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-02-11 | Lecture | Financial Sustainability | Financial Sustainability | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-02-13 | Lecture | Financial Sustainability #2 | Financial Sustainability #2 | M. Hodgson |
| PHARM 413 | Y3 | Winter | 2026-02-23 | Lecture | *Conflict Management | Conflict Management | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-02-25 | Lecture | Leadership 4: Leadership Placement | Leadership 4: Leadership Placement | AHS Team |
| PHARM 413 | Y3 | Winter | 2026-02-27 | Lecture | Personal Selling and Talking about Services | Personal Selling and Talking about Services | L. Guirguis |
| PHARM 413 | Y3 | Winter | 2026-02-27 | Laboratory | Project Open Time - Instructor Available | Project Open Time | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-03-02 | Lecture | Program Evaluation and Quality Improvement | Program Evaluation and Quality Improvement | F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-03-04 | Lecture | Program Evaluation and Research: Outcomes | Program Evaluation and Research: Outcomes | F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-03-06 | Lecture | Program Evaluation and Research: Data collection and analysis | Program Evaluation and Research: Data collection and analysis | F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-03-09 | Lecture | Program Evaluation and Research: Data analysis and reporting | Program Evaluation and Research: Data analysis and reporting | F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-03-11 | Lecture | Implementation of new service | Implementation of new service | F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-03-13 | Lecture | Tips on Writing Executive Summary | Tips on Writing Executive Summary | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-03-16 | Lecture | Application of privacy legislation to the implementation of patient care services | Application of privacy legislation to the implementation of patient care services | J. Shkrobot |
| PHARM 413 | Y3 | Winter | 2026-03-18 | Laboratory | Project Open Time - Instructor Available | Project Open Time | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-03-20 | Lecture | *Women in Leadership | Women in Leadership | A. Oliver |
| PHARM 413 | Y3 | Winter | 2026-03-23 | Lecture | New Pharmacy Service Presentations 1 | New Pharmacy Service Presentations 1 | BASE Team |
| PHARM 413 | Y3 | Winter | 2026-03-23 | Laboratory | Project Open Time - Instructor Available | Project Open Time | J. Shkrobot / F. Sanaee |
| PHARM 413 | Y3 | Winter | 2026-03-25 | Lecture | New Pharmacy Service Presentations 2 | New Pharmacy Service Presentations 2 | BASE Team |
| PHARM 413 | Y3 | Winter | 2026-03-27 | Lecture | New Pharmacy Service Presentations 3 | New Pharmacy Service Presentations 3 | BASE Team |
| PHARM 413 | Y3 | Winter | 2026-03-30 | Lecture | New Pharmacy Service Presentations 4 | New Pharmacy Service Presentations 4 | BASE Team |
| PHARM 413 | Y3 | Winter | 2026-04-01 | Lecture | New Pharmacy Service Presentations 5 | New Pharmacy Service Presentations 5 | BASE Team |
| PHARM 413 | Y3 | Winter | 2026-04-08 | Lecture | New Pharmacy Service Presentations 6 | New Pharmacy Service Presentations 6 | BASE Team |
| PHARM 413 | Y3 | Winter | 2026-04-10 | Lecture | Wrap-Up and Evaluation | Wrap-Up and Evaluation | BASE Team |
Assessment Information
| PHARM 212 | Y1 | Final | Final exam | 60% | Cumulative computer-based final consisting of multiple-choice and short answer questions; weighted 25% pre-midterm, 75% post-midterm. |
| PHARM 212 | Y1 | Midterm | Midterm exam | 30% | Computer-based midterm of multiple-choice and short answer covering content up to Lecture 19 (Oct 15). |
| PHARM 212 | Y1 | Seminars 1-6 | Participation/professionalism | — | Seminars are mandatory; participation/attendance assessed. Excused absences require alternate activity; unexcused absence can result in incomplete. |
| PHARM 212 | Y1 | Team Performance | Participation/professionalism | 5% | Individual peer-evaluation score derived from ITP Metrics anonymous feedback; failure to complete results in zero. |
| PHARM 212 | Y1 | Quizzes (1% each) | Quiz | 5% | Five timed, open-book quizzes (1% each). Multiple choice and open-ended questions. Specific open/close windows listed for Quiz 1-5. |
| PHARM 213 | Y1 | EBCP Literacy Assignment | Assignment/written work | 10% | Individual EBCP literacy assignment on PICO, searching, study design and effect estimates; late penalty 5% per day. |
| PHARM 213 | Y1 | Final Exam | Final exam | 45% | Cumulative computer-based final exam (MCQ and short answer); closed book; weighting ~25% pre-midterm, 75% post-midterm. |
| PHARM 213 | Y1 | Midterm Exam | Midterm exam | 25% | Computer-based, proctored midterm (MCQs and short answer); covers content up to Lecture 21. |
| PHARM 213 | Y1 | Seminars | Participation/professionalism | — | Mandatory seminars with strict attendance requirement; alternate work process described for missed seminars. |
| PHARM 213 | Y1 | Quizzes | Quiz | 20% | Multiple short quizzes (tentative dates listed); mixed formats including MCQ and short answer; written. |
| PHARM 312 | Y2 | Evidence Assignment | Assignment/written work | 20% | Two-part individual assignment: Part 1 (1-page synopsis/appraisal) is completion graded; Part 2 (MCQ/SA) scored; each part = 10% for total 20%. |
| PHARM 312 | Y2 | Final Exam | Final exam | 35% | 110-minute in-person computer-based closed-book final exam (MCQ/SA), non-cumulative, covering Oct 20 onward; time/room TBA. |
| PHARM 312 | Y2 | Midterm Exam | Midterm exam | 35% | 50-minute in-person computer-based closed-book midterm (MCQ/SA) covering material up to Oct 17; accommodations available as noted. |
| PHARM 312 | Y2 | Hospital Pharmacy Visit | Participation/professionalism | — | One mandatory 90-minute in-person hospital pharmacy visit (Edmonton area); registration/sign-up via experiential education team; failure to complete results in course incomplete until done. |
| PHARM 312 | Y2 | Seminar | Participation/professionalism | — | Seminar is a mandatory attendance/completion grade; alternate work required for missed sessions with specific submission requirements; delivery normally in-person but may be remote/blended. |
| PHARM 312 | Y2 | Quizzes | Quiz | 10% | Six Canvas quizzes (MCQ/SA) plus a Syllabus Scavenger Hunt on listed dates; quizzes open prior to due date, answers released and discussed in seminar; missed pre-release quizzes receive zero. |
| PHARM 313 | Y2 | Final | Final exam | 45% | Non-cumulative computer-based final with MCQ and short answer covering Feb 13 through Lecture 37 (Apr 8). |
| PHARM 313 | Y2 | Midterm | Midterm exam | 43% | Computer-based midterm with MCQ and short answer covering lectures and seminars up to Seminar 3 (Feb 12). |
| PHARM 313 | Y2 | Seminars 1-6 | Participation/professionalism | — | Seminars are mandatory active learning sessions; missed seminar requires alternate activity if excused; unaccounted absence can lead to incomplete grade. |
| PHARM 313 | Y2 | Quizzes (3% each) | Quiz | 12% | Four timed open-book quizzes (3% each) with specified open/close windows; must be individual and on time or score zero. |
| PHARM 412 | Y3 | Brief Critical Reflections | Assignment/written work | 20% | 6 BCRs required (some amendments noted); due 11:59 PM two weekdays after lecture; highest subset of scores averaged for 20% of course. |
| PHARM 412 | Y3 | Individual Critical Reflection | Assignment/written work | 10% | 10% individual critical reflection due Dec 1; see HAP instructions. |
| PHARM 412 | Y3 | Pre-Seminar Submissions | Assignment/written work | 5% | Mandatory pre-seminar tasks; follow Seminar Outline; submissions due by 12:50 PM on seminar day. |
| PHARM 412 | Y3 | Project Report | Assignment/written work | 5% | 5% group project report due Nov 17; see HAP Student Instructions on Canvas. |
| PHARM 412 | Y3 | Showcase Presentation | Assignment/written work | 15% | 15% group showcase presentation during Seminar 5; full HAP instructions in Canvas. |
| PHARM 412 | Y3 | Final Exam | Final exam | 30% | 30% final exam (MC and short written), 80-minute limit, covers non-BCR lectures and non-HAP seminars. |
| PHARM 412 | Y3 | Seminar Attendance | Participation/professionalism | — | Attendance mandatory; procedures for missed seminars require notification and Google Form submission within 1 week; late/non-submission may lead to IN or F. |
| PHARM 412 | Y3 | Quizzes | Quiz | 15% | Three timed MC quizzes (5% each) with specified open and close windows; 2-hour time limit once started. |
| PHARM 413 | Y3 | Brief Critical Reflection | Assignment/written work | 5% | Single-lecture reflective submission in What?/So what?/Now what? format; see full description for options and submission instructions. |
| PHARM 413 | Y3 | Implementation Plan Presentation | Assignment/written work | 20% | Team 10-minute oral presentation to judges; slides submitted in advance; rubric on Canvas. |
| PHARM 413 | Y3 | Individual Leadership Reflection | Assignment/written work | 10% | 500-word individual reflection addressing guided questions; details provided in course resources. |
| PHARM 413 | Y3 | New Patient Care Service Written Implementation Plan | Assignment/written work | 30% | Team written proposal (PDF, APA) covering specified headings; rubric on Canvas. |
| PHARM 413 | Y3 | Peer evaluation and Teamwork | Participation/professionalism | 15% | 15% composed of peer assessments after seminars/presentations and individual journals; details and rubric on Canvas. |
| PHARM 413 | Y3 | Seminar | Participation/professionalism | — | Six seminar activities (mandatory), formative and required for project milestones; due the Tuesday after seminar except seminar 6. |
| PHARM 413 | Y3 | Quiz 1 | Quiz | 6% | Canvas quiz (multiple choice/short answer); open Thu 3:00pm to Mon 6:00pm; topics on Canvas. |
| PHARM 413 | Y3 | Quiz 2 | Quiz | 7% | Canvas quiz (multiple choice/short answer); see Canvas for topics and timing. |
| PHARM 413 | Y3 | Quiz 3 | Quiz | 7% | Canvas quiz (multiple choice/short answer); see Canvas for topics and timing. |
About this Evidence
Where did this information come from, and how was it prepared?
What information is included
This curriculum portrait brings together the curriculum records available for the selected stream and academic cycle. These include course information and learning outcomes, documented sessions and topics, assessment information, and links to the CCAPP and AFPC curriculum frameworks.
The amount of descriptive detail varies across academic cycles because the underlying source material is not identical. Current-cycle records are drawn largely from syllabus information, while some earlier-cycle records come from legacy curriculum data that contain less narrative detail. Missing information is left visible rather than filled in.
How topics are connected to curriculum frameworks
Documented curriculum topics are matched to CCAPP curriculum categories with OpenAI assistance. A topic can be matched to more than one CCAPP category when it clearly relates to more than one area.
CCAPP categories are linked to AFPC professional roles. Those links are used to show the AFPC role patterns in the curriculum portrait. These profiles describe where curriculum content is documented. They do not show instructional time, student achievement, or preparedness for practice.
How the charts and percentages are calculated
The values in the charts are calculated directly from the curriculum records. AI-generated text does not calculate these numbers. Each chart is based on a different type of evidence, so percentages from different charts should not be compared as though they use the same starting point.
- Learning outcomes
- Shows the share of classified learning outcomes identified as Knowledge, Skills or Attitudes.
- AFPC roles
- Shows the share of all curriculum links to AFPC professional roles.
- CCAPP topics
- Shows the share of all curriculum links to CCAPP topic categories. One documented topic can contribute to more than one category.
- Delivery
- Uses instructional hours when session-duration information is complete enough for comparison. Otherwise it shows the number of documented sessions.
- Assessment
- Uses assessment weight when comparable weighting information is complete enough. Otherwise it shows the number of documented assessments.
The year-by-year profiles are descriptive comparisons. A visible difference between years does not, by itself, mean that an educationally important change occurred.
How the written summaries are created
The written summaries are built in steps so that broad descriptions remain connected to the underlying curriculum records. Detailed session and assessment information is first organized into summaries for each stream and program year. Those summaries are then used to create the overall stream descriptions shown to reviewers.
AI-assisted writing is used to help produce concise reviewer-facing descriptions from these prepared evidence summaries. It does not calculate the charts or decide whether the curriculum is good, coherent, effective, or whether students have achieved the intended outcomes.
The written summaries are prepared before the report is displayed. Opening or browsing this report does not send a new request to an AI service.
How missing or incomplete information is shown
When the available records are incomplete, the report shows that limitation rather than making an assumption. Examples include missing session duration, incomplete assessment weighting, and older course or assessment records that do not contain the same descriptive detail as newer syllabus-derived records.
For relationships between streams, the same evidence rule is applied from either direction. If there is not enough information to describe a relationship for a particular year and cycle, both stream views show that limitation consistently.